Program: Session (2016 AAAAI Annual Meeting)

0001

30^th Annual Harold S. Nelson Military Allergy/Immunology Symposium TICKETED
Session Details

Thursday, March 3, 2016: 7:20 AM-5:00 PM

JW Marriott, Gold Ballroom Level, Salon 2

8.25 CME/CE

Moderator:

Karla L. Davis , MD FAAAAI

Learning Objectives:

Discuss the approach to identifying and evaluating a patient with eosinophilic esophagitis
Identify and discuss therapies for patients with eosinophilic esophagitis
Discuss the approach to identifying and evaluating a patient with aspirin-exacerbated respiratory disease

7:20 AM

Registration and Breakfast

7:50 AM

Welcome and Introduction
Karla L. Davis, MD FAAAAI

8:00 AM

Morning Address: GeneChips to Corn Flakes: Making Sense of Eosinophilic GI Disease
Calman Prussin, MD FAAAAI

9:00 AM

Break

Fellow Original Research

9:15 AM

Daily Fluctuations in Airborne Ragweed Pollen Levels in Washington, DC (2007-2009)
Sarah W. Spriet, DO

Staff Original Research

9:35 AM

Clinical Impact of the Live Attenuated Vs. Trivalent Inactivated Seasonal Influenza Vaccine on the Efficacy of the Pandemic H1N1 Vaccine
Rachel U. Lee, MD FAAAAI

9:55 AM

Synchronous Telehealth for Outpatient Allergy Consultations: A 2-Year Regional Experience
Kirk H. Waibel, MD FAAAAI

Handouts

Synchronous teleallergy.pdf (636.3 kB)

Fellow Case Reports

10:15 AM

Incongruent Phenotypic Expression of Autosomal Dominant Hyper IgE Syndrome (AD-HIES) in a Mother and Son
Charles J. Calais, DO

10:35 AM

Averting Danger: A Case of Anaphylaxis to Rabavert®
Sarah W. Spriet, DO

10:55 AM

Adult-Diagnosed Chronic Granulomatous Disease
Derek M. Smith, MD

11:15 AM

A Case of Concurrent Hypogammaglobulinemia, Cancer and Cardiomyopathy: A Beta-Catenin Connection?
Camellia Hernandez, MD

11:35 AM

A Case of Neuropathic Pain in Monoclonal Mast Cell Activation Syndrome
Jeannie L. Bay, DO

11:55 AM

Lunch and Bruton Lecture: Aspirin-Exacerbated Respiratory Disease
Andrew A. White, MD FAAAAI

Fellow Case Reports Continued

1:15 PM

Candida Meningitis in a Patient with Complete Myeloperoxidase Deficiency: Beware the “False Positive” DHR
Ki Lee Milligan, MD

1:35 PM

The Atypical Itch That Rashes-- Disseminated and Recurrent Infundibulofolliculitis (Atopic African American Male)
Katherine S. Tille, MD

Resident Case Report

1:55 PM

Elderly Gentleman with Hypereosinophilic Syndrome (HES) Successfully Treated with Mepolizumab
Heung R. Noh, MD

2:15 PM

Armed Forces Immunization Healthcare Center Update
Limone C. Collins Jr., MD

2:45 PM

Military Aeroallergen Extract Laboratory Updates
Susan E. Kosisky, BS MHA

Consultants to the Surgeons General Updates

3:15 PM

VHA Allergy Committee
Joseph S. Yusin, MD FAAAAI

3:30 PM

Air Force
Christopher A. Coop, MD

3:45 PM

Army
Kirk H. Waibel, MD FAAAAI

Handouts

Army Allergy Consultant Update MAIA 2016.pdf (412.6 kB)

4:00 PM

Navy
Michael R. Kaplan, DO FAAAAI

4:15 PM

Panel Discussion: Service-Unique Strategies for Evaluation and Management of Hymenoptera Hypersensitivity

Panel Discussion Speaker
Christopher A. Coop, MD

Panel Discussion Speaker
Michael R. Kaplan, DO FAAAAI

Panel Discussion Speaker
Kirk H. Waibel, MD FAAAAI

Primary Discussion Speaker
Joseph S. Yusin, MD FAAAAI

4:55 PM

Business Meeting and Award Presentations

0101

CEGIR/TIGERS EGID Symposium TICKETED
Session Details

Thursday, March 3, 2016: 8:00 AM-5:00 PM

JW Marriott, Platinum Ballroom Level, Salon DE

7.25 CME/CE

Course

Learning Objectives:

Describe the diagnostic criteria for EoE, eosinophilic gastritis/gastroenteritis/colitis and the controversies in diagnosis
Review the successful current therapeutic options for EoE and review the current triggers for EGIDs
Discuss the pathogenesis as it relates to specific cellular subtypes such as mast cells, eosinophils and T cells

8:00 AM

Welcome

Speaker
Seema Sharma Aceves, MD PhD FAAAAI

Speaker
Marc E. Rothenberg, MD PhD FAAAAI

Speaker
Jonathan M. Spergel, MD PhD FAAAAI

8:15 AM

Introduction to CEGIR
Glenn Furuta, MD

Diagnosis and Monitoring of EGID

8:35 AM

Consensus Guidelines for EoE
Chris A. Liacouras, MD

8:55 AM

Instruments for Monitoring Clinical Parameters in EoE
Alex Straumann, MD

9:15 AM

Consensus Guidelines for Non-EoE EGID
Nirmala Gonsalves, MD

9:35 AM

Guidelines for Diagnosis of EGID
Margaret H. Collins, MD

9:55 AM

Question & Answer

10:05 AM

Break

Breakthroughs Impacting Understanding EGID

10:20 AM

Pathogenesis of Disease
Marc E. Rothenberg, MD PhD FAAAAI

10:40 AM

New Modalities for Surveying the Esophagus
David A. Katzka, MD

11:00 AM

Lymphocyte Involvement in EoE
Wayne Shreffler, MD PhD FAAAAI

11:20 AM

Mast Cells and Basophils in EoE
Joshua B. Wechsler, MD

11:40 AM

Role of Environmental in EoE
Jonathan M. Spergel, MD PhD FAAAAI

12:00 PM

Lunch and Break-Out Sessions: Key Clinical Questions: Problem-Based Learning for Clinical Groups Based on Key Clinical Questions (Attendees can choose one of the following course breakouts; separate registration and ticketing required)

1:30 PM

Cutting-Edge Research Abstracts

Genetics and Risk Factors Associated with EGID

3:00 PM

Gene and Environment Interaction in EoE
Leah Claire Kottyan, PhD

3:20 PM

Epidemiology of EGID
Evan S. Dellon, MD MPH

3:40 PM

Relationships with Connective Tissue Disorders and Other Syndromes
Pamela A. Guerrerio, MD PhD

Controversies in EoE

4:00 PM

Treating Complications of EoE-Fibrosis
Ikuo Hirano, MD

4:15 PM

Emerging Biological Therapy for EoE
Seema Sharma Aceves, MD PhD FAAAAI

4:30 PM

PPI Responsive EoE
Ting Wen, PhD

4:45 PM

Topical Glucocorticoid vs. Diet Therapy
Sandeep K. Gupta, MD

Handouts

Gupta Handout.pdf (1.5 MB)

0201

Advanced Course in Pollen Identification TICKETED
Session Details

Thursday, March 3, 2016: 9:00 AM-12:00 PM

JW Marriott, Gold Ballroom Level, Salon 3

3.00 CME/CE

Course

Moderator:

Estelle Levetin , PhD FAAAAI

Learning Objectives:

Differentiate pollen in the birch family and related triporate pollen types
Discuss difficult to identify tricolporate pollen types
Differentiate Asteraceae pollen, other than ragweed

9:00 AM

Triporate Pollen
Richard W. Weber, MD FAAAAI

9:30 AM

Hands-On Instruction; Question & Answer

10:00 AM

Tricolporate Pollen
Estelle Levetin, PhD FAAAAI

Handouts

Tricolporate Pollen-2016.pdf (513.0 kB)

10:30 AM

Hands-On Instruction; Question & Answer

11:00 AM

Asteraceae Pollen
Peter K. Van de Water, PhD

11:30 AM

Hands-On Instruction; Question & Answer

0101A

Diagnostic Tools I Can Use: What Is the Best for EoE and How to Best Monitor Remission? TICKETED
Session Details

0101B

The Difficult EoE Patient: Bring Your Own Patient TICKETED
Session Details

0101C

The Pipeline of Future EoE Therapy TICKETED
Session Details

0101D

The Ins and Outs of Managing Dietary Therapy TICKETED
Session Details

0101E

Which Skin Testing in EoE? TICKETED
Session Details

0101F

Safety of Topical Glucocorticoids for EoE TICKETED
Session Details

0101G

Role of Ig in EoE TICKETED
Session Details

0101H

The Role of PPIs in Treating Esophageal Eosinophilia TICKETED
Session Details

0101I

How Do I Choose What Treatment to Use? Diet vs. Steroids: Pros and Cons TICKETED
Session Details

0101J

Ask the Experts: EoE Open Mic TICKETED
Session Details

0601

Advanced Course in Fungal Spore Identification TICKETED
Session Details

Thursday, March 3, 2016: 2:00 PM-5:00 PM

JW Marriott, Gold Ballroom Level, Salon 3

3.00 CME/CE

Course

Moderator:

Estelle Levetin , PhD FAAAAI

Learning Objectives:

Differentiate common basidiospores
Differentiate common ascospores
Differentiate Fusarium, Penicillium/Aspergillus and other difficult spore types

2:00 PM

Basidiospore Identification
Estelle Levetin, PhD FAAAAI

Handouts

Basidiospores-2016.pdf (628.2 kB)

2:30 PM

Hands-On Instruction; Question & Answer

3:00 PM

Ascospore Identification
W. Elliott Horner, PhD LEED AP FAAAAI

3:30 PM

Hands-On Instruction; Question & Answer

4:00 PM

Challenging Spore Types
W. Elliott Horner, PhD LEED AP FAAAAI

Challenging Spore Types
Estelle Levetin, PhD FAAAAI

4:30 PM

Hands-On Instruction; Question & Answer

1001

Allergen Immunotherapy, Today and Tomorrow: Session I. Inhalant Allergens for Allergic Rhinitis and Asthma
Session Details

Friday, March 4, 2016: 7:00 AM-9:30 AM

Convention Center, Level One, Petree Hall C

2.50 CME/CE

Course

Moderator:

Alkis Togias , MD FAAAAI

Learning Objectives:

Discuss current and future approaches to allergen immunotherapy for asthma and allergic rhinitis
Discuss the potential mechanisms by which immunotherapy modulates the immune response to allergens
Discuss the durability of immune unresponsiveness induced by allergen immunotherapy

7:00 AM

T Cell Epitope Changes During Allergen Immunotherapy and Allergen Exposure
Alessandro Sette, Dr. Biol. Sci.

7:25 AM

A Unique T Cell Subset (TH2A) in Allergen Immunotherapy
Erik R. Wambre, PhD MBE

7:50 AM

Peptide Immunotherapy in Allergic Rhinoconjunctivitis and Asthma
Mark Larché, PhD

Handouts

LARCHE Handout AAAAI 2016.pdf (86.7 kB)

8:15 AM

Sublingual vs. Subcutaneous Immunotherapy: Which is More Potent?: The GRASS Trial
Stephen R. Durham, MA MD FRCP

8:55 AM

How Can the Risk of Systemic Reactions to Subcutaneous Allergen Immunotherapy be Mitigated?
Tolly Epstein, MD MS FAAAAI

Handouts

1001 course Epstein.pdf (559.2 kB)

9:10 AM

General Discussion

1002

Difficult Cases
Session Details

Friday, March 4, 2016: 7:00 AM-9:30 AM

Convention Center, Level One, Petree Hall D

2.25 CME/CE

Course

Primary Moderators:

Amber M. Patterson , MD FAAAAI
Joyce E. Yu , MD FAAAAI

Learning Objectives:

Discuss diagnostic and clinical management challenges encountered in allergy, asthma and immunology practice

This Session Will Use Audience Response System Technology.

7:00 AM

ABPA/ Hypersensitivity Pneumonitis
Ashwini P. Reddy, MD

ABPA/ Hypersensitivity Pneumonitis
Paul A. Greenberger, MD FAAAAI

7:35 AM

Question & Answer

7:45 AM

Non-IgE Allergic GI Disorders
Stephanie A. Leonard, MD

Non-IgE Allergic GI Disorders
Mirna Chehade, MD MPH

8:20 AM

Question & Answer

8:30 AM

Break

8:45 AM

Difficult to Manage Atopic Dermatitis
Gerald B. Lee, MD

Difficult to Manage Atopic Dermatitis
Luz S. Fonacier, MD FAAAAI

9:20 AM

Question & Answer

1003

Is it Possible to Reprogram a Broken Immune System? How Translational Research is Shifting the Treatment Paradigm from Symptom Management to Cure
Session Details

Friday, March 4, 2016: 7:00 AM-9:30 AM

Convention Center, Level Two, Room 404AB

2.50 CME/CE

Course

Moderator:

Kathryn E. Hulse , PhD

Learning Objectives:

Discuss how genetic factors and the environment interact to determine allergic sensitization
Identify potential targets for prevention and treatment
Discuss different types of treatment for allergic diseases

7:00 AM

Natural Tolerance: How Most of Us Can Eat, Breath and Not Use Steroids
Natalija Novak, MD

Handouts

Handout Novak.pdf (152.4 kB)

7:25 AM

Question & Answer

7:30 AM

Immunotherapy: The Future of the Oldest Treatment of Allergic Diseases
Rudolf Valenta, MD

7:55 AM

Question & Answer

8:00 AM

Microbiome Manipulation: Can We Use Our Ecosystem to Our Advantage?
Nicholas W. Lukacs, PhD

8:25 AM

Question & Answer

8:30 AM

Cellular Manipulation: How Can We Effectively Educate T Regs?
Rosa Bacchetta, MD

8:55 AM

Question & Answer

9:00 AM

Gene Therapy: What Have We Learned from Single Gene Defects?
Jennifer M. Puck, MD

9:25 AM

Question & Answer

1004

Markers of Allergic Inflammation
Session Details

Friday, March 4, 2016: 7:00 AM-9:30 AM

Convention Center, Level Two, Theatre (Room 411)

2.50 CME/CE

Course

Moderator:

Dean D. Metcalfe , MD FAAAAI

Learning Objectives:

Describe the surrogate markers of mast cell, eosinophil and basophil activation
Describe the most reproducible and specific markers
Describe laboratory testing and use of surrogate markers of inflammation in clinical studies

7:00 AM

Allergic Inflammation: Value of Mast Cell Proteases as Surrogate Markers
Lawrence B. Schwartz, MD PhD FAAAAI

7:20 AM

Question & Answer

7:30 AM

Lipid Mediators: PGD2/ LTC4/D4
Sven-Erik Dahlén, MD PhD

7:50 AM

Question & Answer

8:00 AM

Surrogate Markers of Basophil and Eosinophil Activation
Bruce S. Bochner, MD FAAAAI

Handouts

Bochner eos and baso activation final.pdf (4.8 MB)

8:20 AM

Question & Answer

8:30 AM

Clinical Significance of Novel Assays to Measure Granule Protein Expression in Eosinophilic Disease
Amy D. Klion, MD

8:50 AM

Question & Answer

9:00 AM

Surface Markers of Mast Cell and Basophil Activation and Their Value in Diagnosis (Including Basophil Activation Test)
Sarbjit S. Saini, MD FAAAAI

Handouts

Hoffmann_et_al-2015-Allergy.pdf (461.9 kB)

9:20 AM

Question & Answer

1006

Masqueraders of Anaphylaxis/Angioedema
Session Details

Friday, March 4, 2016: 7:00 AM-9:30 AM

Convention Center, Level Two, Room 408B

2.50 CME/CE

Course

Moderator:

Michael M. Frank , MD FAAAAI

Learning Objectives:

Describe uncommon causes of anaphylaxis-type symptoms and angioedema, including HAE, Gleich syndrome, familial tryptasemia/mast cell activation syndromes, idiopathic anaphylaxis and the systemic capillary leak syndrome
Describe the cutting-edge research regarding the biology of rarer causes of anaphylactic symptoms and angioedema
Discuss how this new information can be applied to understanding anaphylactoid symptoms in humans and how these cell types can potentially be modulated to treat patients

7:00 AM

The Systemic Capillary Leak Syndrome
Kirk M. Druey, MD

Handouts

Course 1006 Handouts.pdf (246.8 kB)

Seminar 1006-SCLS_handout.pdf (102.0 kB)

7:20 AM

Question & Answer

7:25 AM

Familial Tryptasemia/MCAS
Joseph H. Butterfield, MD FAAAAI

7:45 AM

Question & Answer

7:50 AM

HAE
Bruce L. Zuraw, MD

8:10 AM

Question & Answer

8:15 AM

HAE with Normal C1 INH
Marco Cicardi, MD

8:35 AM

Question & Answer

8:40 AM

Gleich Syndrome
Paneez Khoury, MD

9:00 AM

Question & Answer

9:05 AM

Idiopathic Anaphylaxis
Melody C. Carter, MD FAAAAI

9:25 AM

Question & Answer

1007

Endoscopic Evaluation and Management of Chronic Rhinosinusitis (Pre- and Post-Surgery) Including Cultures
Session Details

Friday, March 4, 2016: 7:00 AM-9:30 AM

Convention Center, Level Two, Room 409AB

2.50 CME/CE

Course

Moderator:

Jerald W. Koepke , MD FAAAAI

Learning Objectives:

Describe the anatomy of the paranasal sinuses with specific focus on structures that are of pathophysiological and surgical relevance
Discuss radiological modalities and their usage in CRS diagnosis
Describe typical radiological findings in CRS and the usage and limitations of endoscopic evaluation of the nose and sinuses before and after surgery

7:00 AM

Anatomy of the Sinuses
Robert C. Kern, MD

7:35 AM

Question & Answer

7:50 AM

Radiology of the Sinuses
Achilles G. Karagianis, DO

Handouts

radiology of the sinuses.pdf (6.1 MB)

8:25 AM

Question & Answer

8:40 AM

Endoscopic Evaluation of the Sinuses (Pre- and Post-Surgery) Including Cultures: Case Management Studies
Wellington S. Tichenor, MD FAAAAI

Handouts

2016 endoscopy course #1007.pdf (79.7 kB)

9:15 AM

Question & Answer

1008

Pathogenesis of Chronic Rhinosinusitis
Session Details

Friday, March 4, 2016: 7:00 AM-9:30 AM

Convention Center, Level Two, Room 502A

2.50 CME/CE

Course

Moderator:

Tanya M. Laidlaw , MD FAAAAI

Learning Objectives:

Discuss the role of TSLP and its metabolic products in the inflammation of nasal polyps
Recognize the mechanisms by which IL-33 contributes to the pathogenesis of CRS with nasal polyps and the potential to target this cytokine in therapy
Identify the mechanisms by which PGD2 directs inflammation in rhinosinusitis and nasal polyps and become aware of unique aspects of the pathology and pathophysiology of nasal polyp disease in Asia and in Europe

7:00 AM

Role of TSLP in Chronic Rhinosinusitis with Nasal Polyps
Atsushi Kato, PhD

7:20 AM

Question & Answer

7:30 AM

Role of IL-33 in Chronic Rhinosinusitis with Nasal Polyps
Joshua A. Boyce, MD FAAAAI

7:50 AM

Question & Answer

8:00 AM

Role of Prostaglandin D2 in Chronic Rhinosinusitis with Nasal Polyps
Katherine N. Cahill, MD

Handouts

Prostaglandin D2 in the Pathogenesis of CRS.pdf (618.3 kB)

8:20 AM

Question & Answer

8:30 AM

Role of the Microbiome in Chronic Rhinosinusitis and Risk of Nasal Polyposis
Marek L. Kowalski, MD PhD

8:50 AM

Question & Answer

9:00 AM

Role of Staphylococcus Aureus in Chronic Rhinosinusitis with Nasal Polyps
Claus Bachert, MD PhD

9:20 AM

Question & Answer

1009

Best Social Media Practices for Allergists: How to be a Social Media Superstar TICKETED
Session Details

Friday, March 4, 2016: 7:00 AM-9:30 AM

Convention Center, Level Two, Room 405

2.50 CME/CE

Course

Moderator:

Giselle Mosnaim , MD MS FAAAAI

Learning Objectives:

Discuss how to setup a Twitter account and learn how to use it to connect with patients and colleagues
Discuss how to setup a Facebook professional page and learn how to use it to connect with patients and colleagues
Identify what a free blog is and learn how to use YouTube to embed and record videos to maintain an interactive website for your practice

Bring Your Mobile Device to Participate.

7:00 AM

How to Use Blogging for an Allergist’s Practice
Nathaniel D. Hare, MD FAAAAI

7:25 AM

Question & Answer/ Hands-On Instruction

7:37 AM

How to Use Facebook for an Allergist’s Practice
Daniel A. Ramirez, MD

8:02 AM

Question & Answer/ Hands-On Instruction

8:14 AM

How to Use Twitter for an Allergist’s Practice
Matthew S. Bowdish, MD FAAAAI

Handouts

How to use Twitter in an Allergy Practice 1009 Handout.pdf (2.0 MB)

8:39 AM

Question & Answer/ Hands-On Instruction

8:51 AM

How to Use YouTube for an Allergist’s Practice
Sakina S. Bajowala, MD FAAAAI

9:16 AM

Question & Answer/ Hands-On Instruction

1010

Problem-Based Learning: COPD Overlap Syndrome TICKETED
Session Details

Friday, March 4, 2016: 7:00 AM-9:30 AM

Convention Center, Level Two, Room 518

2.50 CME/CE

Course

Learning Objectives:

Describe the diagnostic criteria for COPD and asthma
Discuss how these entities may overlap in some patients
Describe how to incorporate older and newer therapeutic options for these patient groups

This Session Will Use a Problem-Based Learning Approach.

PBL Facilitator
Ray S. Davis, MD FAAAAI

7:00 AM

PBL Case Presentation
Ray S. Davis, MD FAAAAI

7:50 AM

Is it Asthma? COPD? Both?
Timothy J. Craig, DO, FAAAAI

8:10 AM

Pathophysiologic Features and Basis of ACOS
Donald P. Tashkin, MD

8:30 AM

DDX of the Patient with Suspected ACOS
Elliot Israel, MD FAAAAI

8:50 AM

Therapeutic Approaches to ACOS
John Oppenheimer, MD FAAAAI

Handouts

ACOS final1.pdf (1.6 MB)

9:10 AM

Panel Discussion

1012

FIT Symposium TICKETED
Session Details

Friday, March 4, 2016: 7:00 AM-1:45 PM

JW Marriott, Diamond Ballroom Level, Salon 5

0.00 CME/CE

Symposium

Moderator:

Becky J. Buelow , MD

Learning Objectives:

Discuss the mechanisms of asthma
Describe the advances of treatment in childhood asthma
Discuss the biologic treatments of asthma and how these relate to different asthma phenotypes

This Session Will Use Audience Response System Technology.

7:00 AM

Networking Breakfast

7:40 AM

Introductions

Speaker
Becky J. Buelow, MD

Speaker
Mariana C. Castells, MD PhD FAAAAI

7:50 AM

Networking Organizations

8:00 AM

American Board of Allergy and Immunology
Stephen I. Wasserman, MD FAAAAI

8:10 AM

Mechanisms in the Cause of Asthma: Roundtable Discussion of the Experts

Microbial Agents
Mitchell H. Grayson, MD FAAAAI

Air Quality/Pollution
David B. Peden, MD MS FAAAAI

Exercise and Asthma
Thomas A.E. Platts-Mills, MD PhD FAAAAI

Microbiome
Susan V. Lynch, PhD

Genetics of Asthma
Kathleen C. Barnes, PhD FAAAAI

9:20 AM

Break

9:35 AM

AAAAI President Welcome
Robert F. Lemanske Jr., MD FAAAAI

9:45 AM

Advances in the Treatment of Childhood Asthma
Robert F. Lemanske Jr., MD FAAAAI

10:15 AM

Table Discussion: Treatment of Childhood Asthma (Members of the Asthma Diagnosis, Assessment and Treatment Committee, NAIA members or members of the Program Directors Assembly to lead discussions at each table)

10:45 AM

Current and Emerging Biologic Treatments for Asthma
Elliot Israel, MD FAAAAI

11:15 AM

Define Asthma Phenotypes and Their Use in Clinical Medicine
Sally E. Wenzel, MD FAAAAI

11:45 AM

Table Discussion: Using Biologics in the Treatment of Asthma/Difficult Cases (Members of the Asthma Diagnosis, Assessment and Treatment Committee, NAIA members or members of the Program Directors Assembly to lead discussions at each table)

12:15 PM

Networking Lunch

1050

(Invite Only) Chrysalis Project Program TICKETED
Session Details

Friday, March 4, 2016: 7:30 AM-1:45 PM

JW Marriott, Diamond Ballroom Level, Salon 4

0.00 CME/CE

Other

7:30 AM

Breakfast

8:00 AM

Welcome from Chrysalis Chairs

Speaker
A. Wesley Burks, MD FAAAAI

Speaker
Kimberly A. Risma, MD PhD FAAAAI

8:05 AM

Welcome from the AAAAI President-Elect
Thomas A. Fleisher, MD FAAAAI

8:15 AM

Food Allergy
A. Wesley Burks, MD FAAAAI

8:45 AM

Eosinophilic Disorders
Patricia C. Fulkerson, MD PhD

9:15 AM

Immunodeficiency
Thomas A. Fleisher, MD FAAAAI

9:45 AM

Break

10:00 AM

Asthma
Rohit Katial, MD FAAAAI

10:30 AM

Atopic Dermatitis
Donald Y.M. Leung, MD PhD FAAAAI

11:00 AM

Academic Career Paths
Kimberly A. Risma, MD PhD FAAAAI

11:20 AM

Industry Career Paths
Dale T. Umetsu, MD PhD FAAAAI

11:40 AM

Private Practice Career Paths
John Ramey, MD FAAAAI

12:00 PM

Chrysalis Project Program: Class of 2016 Participant Photo

12:15 PM

Chrysalis Project Program Luncheon with FIT Mentors, Chrysalis Faculty and Chrysalis Workgroup Members

1101

Allied Health: Should Allergists and Otolaryngologists Practice Together?
Session Details

1102

Allied Health: Advanced Practice Course
Session Details

Friday, March 4, 2016: 8:00 AM-12:30 PM

Convention Center, Level Two, Room 515A

4.00 CME/CE

Course

Moderator:

Nina A. Zimmermann , MSN RN ANP-BC AE-C

Learning Objectives:

Apply current evidence-based information to clinical practice

8:00 AM

Introduction
Nina A. Zimmermann, MSN RN ANP-BC AE-C

8:15 AM

Update on COPD
Nina A. Zimmermann, MSN RN ANP-BC AE-C

9:00 AM

Look Before You LEAP (Prevention of Allergic Disease)
Rosan Meyer, PhD RD

Handouts

Look Before You LEAP - AAAAI 2016 Handouts final.pdf (979.4 kB)

9:45 AM

Break

10:00 AM

Moving from Management to Treatment with Food Allergies
Pamela H. Steele, MSN CPNP AE-C

10:45 AM

The Link between Vitamin D and the Treatment of Asthma

Speaker
Karen L. Gregory, DNP APRN-BC RRT AE-C

Handouts

AAAAI 2016 Vitamin D Rance K Gregory K final HO.pdf (899.4 kB)

Speaker
Karen S. Rance, DNP APRN CPNP AE-C

11:30 AM

Break

11:45 AM

Taking an Effective Patient History
Gregory M. Metz, MD

Handouts

MetzhandoutAAAAI2016.pdf (181.8 kB)

1151

Allied Health: Marketing for the Allergy Practice
Session Details

1201

Allergen Immunotherapy, Today and Tomorrow: Session II. Immunotherapy with Food Allergens
Session Details

Friday, March 4, 2016: 10:00 AM-12:30 PM

Convention Center, Level One, Petree Hall C

2.50 CME/CE

Course

Moderator:

Marshall Plaut , MD FAAAAI

Learning Objectives:

Discuss current and future approaches to allergen immunotherapy for food allergy
Discuss the potential mechanisms by which immunotherapy modulates the immune response to allergens
Discuss the durability of immune unresponsiveness induced by allergen immunotherapy or by ingestion of food allergens beginning in infancy

10:00 AM

Epicutaneous Peanut to Treat Peanut Allergy
Stacie M. Jones, MD

10:25 AM

Question & Answer

10:30 AM

Insights from New Mechanistic Studies on Food Allergy
Cecilia Berin, PhD

10:55 AM

Question & Answer

11:00 AM

Low Dose Immunotherapy in Very Young Children to Treat Peanut Allergy
Brian P. Vickery, MD FAAAAI

11:25 AM

Question & Answer

11:30 AM

Epigenetic Changes during Food Allergen Immunotherapy
Kari C. Nadeau, MD PhD FAAAAI

11:55 AM

Question & Answer

12:00 PM

Does Tolerance to Peanut Persist After Prolonged Avoidance? The LEAP-On Study
Gideon Lack, MD

12:25 PM

Question & Answer

1202

Diagnostic Challenges in Mastocytosis: Serum Tryptase, Allele-Specific PCR and GI Pathology
Session Details

Friday, March 4, 2016: 10:00 AM-12:30 PM

Convention Center, Level One, Petree Hall D

2.50 CME/CE

Course

Moderator:

Catherine R. Weiler , MD PhD FAAAAI

Learning Objectives:

Discuss utility and interpretation of elevated tryptase level
Discuss which cases can be evaluated at general allergist level and when a referral to a mastocytosis center is indicated
Discuss utility and interpretation of allele-specific PCR and indications for bone marrow biopsy

This Session Will Use Audience Response System Technology.

10:00 AM

My Patient Has Elevated Tryptase. Now What?
Joseph H. Butterfield, MD FAAAAI

10:20 AM

Question & Answer

10:30 AM

KIT Mutational Analysis: Allele-Specific PCR
Dean D. Metcalfe, MD FAAAAI

10:50 AM

Question & Answer

11:00 AM

Mast Cells in the GI Tract: Is It Mastocytosis?
Cem Akin, MD PhD FAAAAI

11:20 AM

Question & Answer

11:30 AM

Value of Flow Cytometry in Diagnosis of Mastocytosis: Advantages and Pitfalls
Alberto Orfao, MD, PhD

11:50 AM

Question & Answer

12:00 PM

Hymenoptera Anaphylaxis: When to Suspect Mastocytosis?
Patrizia Bonadonna, MD CME

Handouts

Hymenoptera Anaphylaxis When to Suspect Mastocytosis AAAAI 2016 Bonadonna.pdf (4.0 MB)

12:20 PM

Question & Answer

1203

NIEHS: Autophagy and Phagocytosis: At the Crossroads of Inflammation and Tolerance
Session Details

Friday, March 4, 2016: 10:00 AM-12:30 PM

Convention Center, Level Two, Room 404AB

2.50 CME/CE

Course

Moderator:

Jennifer Martinez , PhD

Learning Objectives:

Identify the role of phagocytosis and autophagy in the modulation of the innate immune response
Discuss the role of the autophagy machinery in antigen presentation and modulation of the adaptive immune response
Examine the role of phagocytosis and autophagy in the pathogenesis of autoimmune disorders

10:00 AM

The Interplay Between the Autophagy Machinery and Innate Immunity
Nicholas W. Lukacs, PhD

10:18 AM

Question & Answer

10:25 AM

Connecting Autophagy, Phagocytosis and Antigen Presentation
Julie Magarian Blander, PhD

10:43 AM

Question & Answer

10:50 AM

Phagocytosis and Lipid Sensing: Molding the Metabolic Profile
Ruoning Wang, PhD

11:08 AM

Question & Answer

11:15 AM

LC3-Associated Phagocytosis as a Critical Regulator of the Innate Immune Response
Jennifer Martinez, PhD

11:33 AM

Question & Answer

11:40 AM

Differential Cell Death Pathways Can Alter the Innate Immune Response
Francis Ka Ming Chan, PhD

11:58 AM

Question & Answer

12:05 PM

Efferocytosis and Prevention of Autoimmune Disorders
Kodi S Ravachandran, PhD

12:23 PM

Question & Answer

1204

Introductory Course in Rhinolaryngoscopy with Hands-On Instruction TICKETED
Session Details

Friday, March 4, 2016: 10:00 AM-12:30 PM

Convention Center, Level Two, Room 407

2.50 CME/CE

Course

Moderator:

Jerald W. Koepke , MD FAAAAI

Learning Objectives:

Describe the surgical anatomy of the upper airway, including the nasal cavity, pharynx and larynx
Identify examples of normal and abnormal anatomy, as well as disease presentations and post-operative changes found with endoscopic examination of the upper airway
Identify indications for and the use of the fibreoptic rhinoscope in the allergist´s office

10:00 AM

Introductory Course in Rhinolaryngoscopy with Hands on Instruction
Jerald W. Koepke, MD FAAAAI

Handouts

2016.03.04 Rhinolaryngoscopy Introductory Course HO - J.W. Koepke MD .pdf (1.8 MB)

11:15 AM

Hands-On Instruction

Hands-on Instruction
Allen D. Adinoff, MD FAAAAI

Hands-on Instruction
Kevin R. Murphy, MD

Hands-on Instruction
Grant C. Olson, MD

Handouts

For handouts.pdf (85.4 kB)

Hands-on Instruction
Donald W. Pulver, MD FAAAAI

Hands-on Instruction
C. Ross Westley, MD FAAAAI

1205

Lessons from Functional Genomics: New Data from the AADCRC
Session Details

Friday, March 4, 2016: 10:00 AM-12:30 PM

Convention Center, Level Two, Room 408A

2.50 CME/CE

Course

Moderator:

Angela Haczku , MD PhD FAAAAI

Learning Objectives:

Discuss the new information available about the genetic regulation of allergic disease that can be practically applied to patient care
Discuss the most recent data from large population cohorts that inform our therapeutic approach
Discuss new insights into ORMDL3 and allergic disease

10:00 AM

Asthma: Genomics Approaches to New Treatments
Gurjit K. Khurana Hershey, MD PhD FAAAAI

10:40 AM

Question & Answer

10:50 AM

Eosinophilic Gastrointestinal Disorders
Marc E. Rothenberg, MD PhD FAAAAI

11:30 AM

Question & Answer

11:40 AM

Novel Insights into the Contribution of ORMDL3 in Asthma
Benjamin A. Raby, MD MPH

12:20 PM

Question & Answer

1206

Inflammatory Origins of CRS: Uncovering Opportunities for Disease Prevention and Modification
Session Details

Friday, March 4, 2016: 10:00 AM-12:30 PM

Convention Center, Level Two, Room 408B

2.50 CME/CE

Course

Moderator:

David W. Hauswirth , MD FAAAAI

Learning Objectives:

Describe the role of the microbiome and biofilms in the development of CRS
Discuss the implications of antibiotic use and overuse in CRS
Identify inflammatory pathways in CRS and opportunities for disease modification

10:00 AM

The Role of Biofilms and the Microbiome in the Development of CRS
Robert C. Kern, MD

10:30 AM

Negative Effects of Antibiotics in Origins of CRS
Martin Wagenmann, MD FAAAAI

11:00 AM

Question & Answer Panel Discussion

11:15 AM

Antibody Deficiency: Epidemiological, Clinical and Pathological Overlap with CRS
Anju T. Peters, MD FAAAAI

11:45 AM

Biologics in Chronic Rhninosinusitis with Nasal Polyps: Current State and Future Role
Claus Bachert, MD PhD

Handouts

Biologics JACI 2015.pdf (1.6 MB)

12:15 PM

Question & Answer Panel Discussion

1207

How to Apply for and Obtain an NIH Grant for the New Investigator TICKETED
Session Details

Friday, March 4, 2016: 10:00 AM-12:30 PM

Convention Center, Level Two, Room 405

2.50 CME/CE

Course

Moderator:

Larry Borish , MD FAAAAI

Learning Objectives:

Describe the system of NIH funding mechanisms
Critically evaluate grant applications

Attendees will be Required to Submit a One to Three Page Grant Proposal Consisting Primarily of Hypotheses and Specific Aims to Participate in this Course.

10:00 AM

NIH Grants as Seen from the NIAID
Alkis Togias, MD FAAAAI

10:15 AM

Grants as Seen from the NIH
Mike Minnicozzi, PhD

10:30 AM

Panel Discussion

Panelist
Larry Borish, MD FAAAAI

Panelist
R. Stokes Peebles Jr., MD FAAAAI

Panelist
Nora A. Barrett, MD FAAAAI

Panelist
Tanya M. Laidlaw, MD FAAAAI

11:00 AM

Small Group Discussion with Session Faculty to Review Grant Applications

1208

Finding a Job and Getting Started in Practice
Session Details

Friday, March 4, 2016: 10:00 AM-12:30 PM

Convention Center, Level Two, Room 502A

2.50 CME/CE

Course

Moderator:

Weily Soong , MD FAAAAI

Learning Objectives:

Discuss the changing landscape of American medicine and the practice of allergy
Explain how to identify and join the right practice opportunity
Discuss the fundamentals of office management, identify strategies for marketing a practice, and review tips on building a patient base

10:00 AM

Overview of AAAAI, Office of Practice Management and RSLAAIS
Sharon B. Markovics, MD FAAAAI

10:05 AM

Overview of the Changing Healthcare Market and the Allergy Market
David L. Patterson, MD MS MBA FAAAAI

Handouts

References 2016 PDF.pdf (30.0 kB)

10:35 AM

Finding a Job, Different Practice Opportunities (Single, Multi-Specialty, Academics), and Different Types of Practices
Tao T. Le, MD MHS FAAAAI

11:10 AM

Question & Answer

11:20 AM

Practice Finances 101: For Private Practice and Academics
Vinay Mehta, MD FAAAAI

Handouts

Practice Finance 101.pdf (852.7 kB)

11:55 AM

Marketing Your Practice and Referral Development
Stanley M. Fineman, MD MBA FAAAAI

Handouts

AAAAI handout start in pract.pdf (1.8 MB)

12:20 PM

Question & Answer

1209

Making Your Technology Work for You
Session Details

Friday, March 4, 2016: 10:00 AM-12:30 PM

Convention Center, Level Two, Room 502B

2.50 CME/CE

Course

Moderator:

Anne K. Ellis , MD MSc FAAAAI

Learning Objectives:

Discuss how technology can assist in work flow from the beginning to the end, utilizing the EMR to the fullest
Discuss social media and marketing tools for the practice
Discuss and provide an introduction to telemedicine

Bring Your Mobile Device to Participate.

10:00 AM

Making the Technology Work and Pay Off for Your Practice
Nabeel Farooqui, MD

10:25 AM

My EMR Is Too Much Work! Maximizing Productivity Now That You Have Your EMR
Priya J. Bansal, MD FAAAAI

Handouts

My EMR is too much work- session 1209.pdf (20.8 kB)

10:50 AM

Social Media Tools for Marketing and Communications
Sakina S. Bajowala, MD FAAAAI

11:15 AM

Educating Our Patients through Technology: How to Create Handouts, Videos and More
Ves Dimov, MD

11:35 AM

iPhones, iPads, and Androids: New Apps and Tools to Assist in Your Practice
Melinda M. Rathkopf, MD FAAAAI

Handouts

AAAAI 2016 1209.pdf (41.9 kB)

11:55 AM

Telemedicine: The New Frontier
Chitra Dinakar, MD FAAAAI

Handouts

AAAAI Telemed Presentation Dinakar for upload 1209.pdf (582.1 kB)

12:15 PM

Question & Answer

1210

The Principles of Healthy Homes and Using Home Environmental Assessment in Disease Management
Session Details

Friday, March 4, 2016: 10:00 AM-12:30 PM

Convention Center, Level One, Concourse Hall Room 152

2.50 CME/CE

Course

Moderator:

James W. Sublett , MD

Learning Objectives:

Recognize potentially harmful respiratory exposures in homes including allergens, mold, pests, particulate, and other pollutants
Identify the seven principles of healthy housing
Describe how to collaborate with environmental professionals to make healthy homes a reality

This Session Will Use Audience Response System Technology.

10:00 AM

Principles of a Healthy Home
Kevin Kennedy, MPH CIEC

Handouts

CMH Environmental Assessment Referral.pdf (119.7 kB)

CMH Consent Agreement for Assessment.pdf (839.4 kB)

10:35 AM

Question & Answer

10:50 AM

Taking an Environmental Health History
Wanda Phipatanakul, MD MS FAAAAI

Handouts

AAAAI_03_04_2015_Env_History10AM_NewHANDOUT.pdf (845.3 kB)

11:25 AM

Question & Answer

11:40 AM

Communicating Findings and Reporting Assessment Results
Jay M. Portnoy, MD FAAAAI

12:15 PM

Question & Answer

1211

NHLBI: Incorporating New Methodology in Asthma Clinical Trials TICKETED
Session Details

Friday, March 4, 2016: 10:00 AM-12:30 PM

Convention Center, Level Two, Room 515B

2.50 CME/CE

Course

Moderator:

Christine A. Sorkness , PharmD

Learning Objectives:

Discuss how the age of the study population affects asthma clinical trials
Discuss the process of data collection for biologic specimens and clinical data in asthma trials
Discuss how data is converted into clinically meaningful information for patients with asthma

10:00 AM

Cross-Age Studies: Important Decisions
Stanley J. Szefler, MD FAAAAI

Handouts

Szefler 1211 V2 HANDOUT Asthma Across Ages 030416.pdf (8.9 MB)

10:20 AM

Question & Answer

10:25 AM

Microbiome: Challenges and Opportunities
Susan V. Lynch, PhD

10:45 AM

Question & Answer

10:50 AM

Monitoring Asthma Control in Clinical Trials
David Mauger, PhD

11:10 AM

Question & Answer

11:15 AM

Composite Outcomes: Strengths and Weaknesses
Daniel J. Jackson, MD

11:35 AM

Question & Answer

11:40 AM

Case Study: Small Group Discussion

12:05 PM

Small Group Report-Out

12:20 PM

Panel Discussion Question & Answer

1301

Allied Health: The Allergist's Coding Update for 2016
Session Details

1401

Allied Health: Ask-the-Expert Question & Answer Roundtable Luncheon TICKETED
Session Details

Friday, March 4, 2016: 12:30 PM-1:45 PM

Convention Center, Level Two, Room 410

1.25 CME/CE

Workshop

Moderator:

John D. Milewski , FACMPE, MSHA

Learning Objectives:

Discuss billing, coding, ICD-10, PCMH for the allergist, staff training and collection strategies for high deductible plans
Identify hot-topic subjects and address issues that arise in practice

Billing, Coding and ICD-10 Question & Answer
Teresa Thompson, CPC CMSCS CCC

PCMH for the Allergist
Thomas J. Derrico

Collection Strategies for High Deductible Plans
Joan E. Hawkins, CMM

Compliance: HIPAA
Mary H. Thal, BS RN

Vertical Integration: What's the Next Step?
Robert A. Glazer, MBA

Staff Training and Motivation
Ron Hartley, BA

Question & Answer

1501

JACI: Year-in-Review TICKETED
Session Details

Friday, March 4, 2016: 12:30 PM-1:45 PM

Convention Center, Level Two, Room 403A

1.25 CME/CE

Workshop

Moderator:

Cezmi A. Akdis , MD FAAAAI

Learning Objectives:

Discuss and provide an update on the cutting edge literature on atopic dermatitis, food allergy, and asthma, in regards to pathogenesis, treatment and prevention

This Session Requires Pre-Meeting Reading.

12:30 PM

Atopic Dermatitis
Kenji Kabashima, MD PhD

12:45 PM

Question & Answer

12:55 PM

Asthma
Harald Renz, MD FAAAAI

1:10 PM

Question & Answer

1:20 PM

Eosinophilic Esophagitis
Robert A. Wood, MD FAAAAI

1:35 PM

Question & Answer

1502

Dilemmas in Asthma Management
Session Details

1503

ILC2: Gateway to Th2 Inflammation
Session Details

Friday, March 4, 2016: 12:30 PM-1:45 PM

Convention Center, Level Two, Theatre (Room 411)

1.25 CME/CE

Workshop

Moderator:

David H. Broide , MB ChB FAAAAI

Learning Objectives:

Discuss how ILC2 contributes in a substantial way to the induction of allergic skin diseases
Describe ILC2 cells that have important regulatory roles in the balance between maintenance of normal gut homeostasis and establishment of inflammatory bowel disease
Identify mechanisms by which ILC2 contributes to asthma pathogenesis

12:30 PM

ILC2 as Regulators of Allergic Dermatitis
Brian S. Kim

12:50 PM

Question & Answer

12:55 PM

ILC2 in Gut Immunity
Ari B Molofsky

1:15 PM

Panel Discussion

1:20 PM

ILC2 in the Pathogenesis of Allergic Lung Disease
Hirohito Kita, MD

1:40 PM

Question & Answer

1504

SLIT Practical Considerations, Unmet Needs and FAQs
Session Details

1505

FPIES: What We Know, What We Don't Know and What We Still Need to Know TICKETED
Session Details

Friday, March 4, 2016: 12:30 PM-1:45 PM

Convention Center, Level Two, Room 518

1.25 CME/CE

Workshop

Moderator:

Terri F. Brown-Whitehorn , MD

Learning Objectives:

Discuss and appraise consensus guidelines for diagnosis and management of FPIES
Describe nutritional management of FPIES
Describe the unmet needs in FPIES, including epidemiology, pathophysiology and others

Case-Based Discussion

12:30 PM

FPIES: What We Know about Diagnosis and Management of Acute and Chronic Phenotype
Anna H. Nowak-Wegrzyn, MD FAAAAI

Handouts

FPIES workshop.pdf (315.2 kB)

12:45 PM

Question & Answer

12:55 PM

FPIES: What We Know about Nutrition Management
Marion E. Groetch, MS RD

1:10 PM

Question & Answer

1:20 PM

FPIES: What We Still Need to Know about Epidemiology and Pathophysiology
Jean-Christoph Caubet, MD

1:35 PM

Question & Answer

1506

The Safety of Asthma and Allergy Medications During Pregnancy: New Horizons
Session Details

Friday, March 4, 2016: 12:30 PM-1:45 PM

Convention Center, Level Two, Room 409AB

1.25 CME/CE

Workshop

Moderator:

Michael Schatz , MD MS FAAAAI

Learning Objectives:

Identify knowledge gaps regarding the safety of asthma and allergy medications during pregnancy
Optimally use the information provided by the new FDA pregnancy labeling system for clinical decision making
Appreciate the role of VAMPSS in providing new information for the pregnancy label and filling in knowledge gaps regarding the safety of asthma and allergy medications during pregnancy

12:30 PM

The Safety of Asthma and Allergy Medications During Pregnancy: Knowledge Gaps
Jennifer A. Namazy, MD FAAAAI

12:45 PM

The Safety of Asthma and Allergy Medications During Pregnancy: The New FDA Pregnancy Label
Tamara Johnson, MD MS

1:00 PM

The Safety of Asthma and Allergy Medications During Pregnancy: The Role of VAMPSS
Christina Chambers, PhD MPH

1:15 PM

Question & Answer

1510

The Use of Social Media in the Allergy Practice TICKETED
Session Details

1511

Barriers to Asthma Management in Schools TICKETED
Session Details

1512

Whole Exome Sequencing: Guidance in Modalities and Interpretation for the Practicing Immunologist TICKETED
Session Details

1513

The Intricacy of Penicillin and Cephalosporin Allergy Evaluation TICKETED
Session Details

1514

Non-IgE-Mediated Food Allergies TICKETED
Session Details

1551

Allied Health: Precautionary Allergen Labeling Contains Useful Information
Session Details

1801

What Can Implementation Research Teach Us About the Management of Asthma?
Session Details

Friday, March 4, 2016: 4:00 PM-5:15 PM

Convention Center, Level One, Petree Hall C

1.25 CME/CE

Symposium

Moderator:

Giselle Mosnaim , MD MS FAAAAI

Learning Objectives:

Describe and define the role of implementation research to improvement of asthma outcomes
Identify the methodologies for conducting implementation research in asthma
Identify new areas for implementation research in asthma

4:00 PM

What is Implementation Research and How Can it Improve Asthma Outcomes?
Cynthia S. Rand, PhD

4:20 PM

Question & Answer

4:25 PM

Making the Switch from Randomized Trials to Implementation Research
Andrea J. Apter, MD MA MSc FAAAAI

4:45 PM

Question & Answer

4:50 PM

Community-Level Implementation Research Can Address Asthma Disparities
Michelle M. Cloutier, MD

Handouts

Michelle Cloutier 1801.pdf (396.7 kB)

5:10 PM

Question & Answer

1802

Management of Atopic Dermatitis: What's New?
Session Details

1803

Automating Pollen Identification/NAB
Session Details

Friday, March 4, 2016: 4:00 PM-5:15 PM

Convention Center, Level Two, Room 404AB

1.25 CME/CE

Symposium

Moderator:

Dennis K. Ledford , MD FAAAAI

Learning Objectives:

Discuss current laboratory techniques which could permit automated aeroallergen determinations
Review the problems associated with collecting samples for automated aeroallergen assessments
Identify and provide an up-to-date scientific analysis of how soon such techniques will be available to the community

4:00 PM

Flow Cytometry
Michael Teng, PhD

4:20 PM

Question & Answer

4:25 PM

Monoclonal Antibodies
Martin D. Chapman, PhD FAAAAI

Handouts

Chapman 1803 handout FCR.pdf (56.3 kB)

4:45 PM

Question & Answer

4:50 PM

Real Time PCR
Mark C. Glaum, MD PhD FAAAAI

5:10 PM

Question & Answer

1804

B-Regulatory Cells: No Longer Playing Second Fiddle to T Regs
Session Details

Friday, March 4, 2016: 4:00 PM-5:15 PM

Convention Center, Level Two, Theatre (Room 411)

1.25 CME/CE

Symposium

Moderator:

Cezmi A. Akdis , MD FAAAAI

Learning Objectives:

Discuss the prominent role B cells that express PD-L1 occupy in the regulation of humoral immune responses
Describe the settings in which B lymphocytes express IL-10, providing these B cells with potent ability to regulate both innate and adaptive immune responses
Discuss settings in which B lymphocytes may play important roles as modulators of all responses in organ transplantation

4:00 PM

PD-L1hi B Cells Are Critical Regulators of Humoral Immunity
Padraic Fallon, PhD

4:20 PM

Question & Answer

4:25 PM

IL-10 Expressing B Cells Regulate Innate and Adaptive Immune Responses
Mubeccel Akdis, MD PhD

Handouts

StanicJACI2014.pdf (3.1 MB)

4:45 PM

Question & Answer

4:50 PM

Regulatory B Cells and Tolerance in Transplantation
David M. Rothstein, MD

5:10 PM

Question & Answer

1805

Secondary Immune Deficiencies (Non-HIV)
Session Details

Friday, March 4, 2016: 4:00 PM-5:15 PM

Convention Center, Level Two, Room 408A

1.25 CME/CE

Symposium

Moderator:

Christina L. Nance , PhD

Learning Objectives:

Discuss secondary immunodeficiency due to underlying disease states, environmental exposures and other causes
Discuss underlying mechanisms and sequelae of the immune dysfunction of secondary immunodeficiencies

4:00 PM

Secondary Immunodeficiency Due to Underlying Disease States, Environmental Exposures and Miscellaneous Causes
Francisco A. Bonilla, MD PhD FAAAAI

4:20 PM

Question & Answer

4:25 PM

Secondary Immunodeficiency Induced by Drugs and Biologic Therapies
Mark Ballow, MD FAAAAI

Handouts

Session 1805 Secondary Immune Deficiencies.pdf (337.6 kB)

4:45 PM

Question & Answer

4:50 PM

Solid Organ Transplantation and Secondary Antibody Deficiency
Sarah K. Nicholas, MD

5:10 PM

Question & Answer

1806

Non-IgE-Mediated Gastrointestinal Food Allergies in Children and Adults
Session Details

Friday, March 4, 2016: 4:00 PM-5:15 PM

Convention Center, Level Two, Room 408B

1.25 CME/CE

Symposium

Moderator:

Kirsi M. Jarvinen-Seppo , MD PhD FAAAAI

Learning Objectives:

Describe immune responses to foods in the GI tract
Describe manifestations, diagnosis and management of food protein-induced enterocolitis syndrome (FPIES) with emphasis on the evolution of systemic IgE immune response to foods and implications for management
Describe the continuum of immune responses to wheat from childhood to adulthood and potential therapeutic targets

4:00 PM

Pathophysiology of Inflammatory Responses to Food Allergens in the Gut: Potential Targets for Prevention
Simon P. Hogan, PhD

4:20 PM

Question & Answer

4:25 PM

Modification of FPIES Natural History by Evolution of Systemic IgE Responses to Foods
Anna H. Nowak-Wegrzyn, MD FAAAAI

Handouts

ANW-handout-session.pdf (273.1 kB)

4:45 PM

Question & Answer

4:50 PM

Spectrum of Wheat Sensitivity in Children and Adults: Opportunities for Disease Modification
Peter Green, MD

5:10 PM

Question & Answer

1807

Allergy in Schools: Keeping Kids Healthy and Safe
Session Details

Friday, March 4, 2016: 4:00 PM-5:15 PM

Convention Center, Level Two, Room 502A

1.25 CME/CE

Symposium

Moderator:

Carla M. Davis , MD FAAAAI

Learning Objectives:

Discuss and guide management of asthma in schools
Discuss and guide management of anaphylaxis in schools
Describe management of food allergy in schools

4:00 PM

Improving School Management of Food Allergy
Michael C. Young, MD FAAAAI

Handouts

AAAAI Symposium 1807 Improving School Management of Food Allergy.pdf (271.0 kB)

4:20 PM

Question & Answer

4:25 PM

Anaphylaxis in Schools: Challenges and Opportunities
Julie Wang, MD FAAAAI

4:45 PM

Question & Answer

4:50 PM

Enhancing Asthma Care with School-Centered Programs
Wanda Phipatanakul, MD MS FAAAAI

Handouts

Huffaker_Phipatanakul.pdf (170.4 kB)

Szefler.pdf (175.4 kB)

Oppenheimer_Policy_schools.pdf (178.5 kB)

Cloutier_Michelle_2015.pdf (186.2 kB)

03_04_2016_Enhancing_AsthmaSchoolProgramsHandout.pdf (957.4 kB)

5:10 PM

Question & Answer

1808

Microbial Regulation of Allergic Airway Inflammation: Lessons from the AADCRC
Session Details

Friday, March 4, 2016: 4:00 PM-5:15 PM

Convention Center, Level Two, Room 502B

1.25 CME/CE

Symposium

Moderator:

R. Stokes Peebles Jr. , MD FAAAAI

Learning Objectives:

Discuss and define the factors that regulate severity of illness to rhinovirus infection
Identify the mechanisms by which CARDS toxin induces allergic airway inflammation
Describe how virus infection regulates airway epithelial cell function

4:00 PM

Determinants of Rhinovirus Illness Severity
James E. Gern, MD FAAAAI

4:20 PM

Question & Answer

4:25 PM

Regulation and Induction of Airway Inflammation By Mycoplasma Pneumonia CARDS Toxin
Joel Barry Baseman, PhD

Handouts

AAAAI Handout _wPubs_2016 LA mod 2.pdf (1.3 MB)

4:45 PM

Question & Answer

4:50 PM

Viral-Epithelial Interactions in Airway Inflammation
Speaker to be announced.

Handouts

Holtzman Handout.pptx (Read-Only).pdf (2.1 MB)

5:10 PM

Question & Answer

1810

Allied Health Plenary: Working Together to Improve Asthma Care
Session Details

2001

Smoking Cessation in Asthmatics: Behavioral, Pharmacologic and E-Cigarette Modalities TICKETED
Session Details

2002

Performing Outpatient Aspirin Desensitizations for Patients with AERD TICKETED
Session Details

2003

Making Your EMR Work for You TICKETED
Session Details

2004

The Link to Immunodeficiency: Targeted Treatment TICKETED
Session Details

2005

How Allergen Extracts are Made: From Source Materials to Allergen Extracts TICKETED
Session Details

2006

Update in Occupational Allergy: Occupational Anaphylaxis TICKETED
Session Details

2007

Early Barrier Therapy to Prevent and Treat Eczema TICKETED
Session Details

2008

Clinical Challenges in the Prevention of Food Allergy Through Early Introduction TICKETED
Session Details

2009

EoE: Dietary Pitfalls and Practical Management in Children and Adults: Are there Similarities at All? TICKETED
Session Details

2010

Legalization of Cannabis: Implications for the Allergy Care Provider TICKETED
Session Details

2011

Mobile Asthma Care Challenges, Rewards and Reach TICKETED
Session Details

2012

Drug Allergy Testing and Desensitization Protocols in Your Practice TICKETED
Session Details

2013

Prostaglandin Regulation of Allergic Diseases TICKETED
Session Details

2021

Allied Health: Treatment Options for the Young Wheezers TICKETED
Session Details

2022

Allied Health: Cooking and Meal Time with Food Allergy TICKETED
Session Details

2051

Allied Health: With the Changing Market Place of High Deductible Plans How are Clinics Addressing Their Collection Processed to Keep Current with the Trends of the Marketplace?
Session Details

2151

Allied Health: PQRS Compliance in the Allergy Office
Session Details

2251

Allied Health: The Patient-Centered Specialist Program: Becoming a Medical Neighbor
Session Details

2301

World Allergy Forum: Role of Intolerance in Food Allergy
Session Details

Saturday, March 5, 2016: 10:45 AM-12:00 PM

Convention Center, Level One, South Exhibit Hall G

1.25 CME/CE

Symposium

Primary Moderators:

Robert F. Lemanske Jr. , MD FAAAAI
Mario Sánchez-Borges , MD FAAAAI

Learning Objectives:

Identify the worldwide patterns associated with food intolerances
Describe the regimens used for tolerance inductions
Describe new therapeutic options in prevention of food allergy worldwide

10:45 AM

Food Allergy: Worldwide Patterns
Michael E. Levin, MBChB PhD FAAAAI

11:05 AM

Question & Answer

11:10 AM

Potential Regimens for Tolerance Inductions
Susan Prescott, MD PhD

11:30 AM

Question & Answer

11:35 AM

Treatment Prevention and Guidelines Worldwide
Hugh A. Sampson, MD FAAAAI

11:55 AM

Question & Answer

2302

Lessons from Performing Guideline-Driven, Evidence-Based Asthma Interventions in the Real World: Who Benefits?
Session Details

Saturday, March 5, 2016: 10:45 AM-12:00 PM

Convention Center, Level One, Petree Hall D

1.25 CME/CE

Symposium

Moderator:

Anne Markus , JD, PhD, MHS

Learning Objectives:

Describe how to promote effective adaptation when developing an evidence-based intervention, such as ongoing dialogue between researchers and the target healthcare setting to respond to the needs of the clinic while monitoring fidelity to the intervention
Discuss if evidence-based interventions remain effective when translated into populations and healthcare settings that differ from the parent trials, and identify what components may be needed to retain efficacy
Identify and assess if evidence-based asthma interventions are cost effective when translated across several different healthcare settings with various insurance providers, and identify what elements payers are interested in supporting for potential intervention sustainability

10:45 AM

Found in Translation: How to Identify Key Elements of an Evidence-Based Intervention and How They are Adapted and Retained in Clinics Serving Diverse Underserved Communities
David M. Stevens, MD

11:05 AM

Question & Answer

11:10 AM

Effectiveness of the Champs Intervention on Asthma Symptoms and Healthcare Utilization: Implications for Populations and Healthcare Centers That May Benefit from an Evidence-Based Intervention
Suzanne Kennedy, PhD

11:30 AM

Question & Answer

11:35 AM

Incremental Cost-Effectiveness of the Champs Intervention: Implications for Supporting an Evidence-Based Intervention
Avi Dor, PhD

11:55 AM

Question & Answer

2303

New Molecular Breakthroughs in the Study of Immunoglobulin E
Session Details

2304

Epithelium and Innate Immune Responses: Airways and Skin
Session Details

Saturday, March 5, 2016: 10:45 AM-12:00 PM

Convention Center, Level Two, Theatre (Room 411)

1.25 CME/CE

Symposium

Moderator:

Robert P. Schleimer , PhD FAAAAI

Learning Objectives:

Discuss that bitter and sweet taste receptors are present in multiple anatomic compartments and can serve as innate immune system sentinels
Discuss the multiple roles that epithelial cells in the skin serve in host defense and regulators of inflammation
Discuss that epithelial cells in the lung produce many secreted molecules that regulate innate and adaptive immune responses

10:45 AM

The Role of Taste Receptors in Epithelial Immune Responses and Chronic Sinus Disease
Robert J. Lee, PhD

Handouts

RJLee_AAAAI handout_2016.pdf (1.8 MB)

11:05 AM

Question & Answer

11:10 AM

Barrier, Innate Immunity, Commensal Bacteria and Inflammation in the Skin
Kenji Kabashima, MD PhD

11:30 AM

Question & Answer

11:35 AM

Epithelial Responses in the Lungs Drive Innate and Adaptive Immunity
Jay W. Kolls, MD

Handouts

Kolls AAAAI handout 2016 02152016.pdf (11.5 kB)

11:55 AM

Question & Answer

2305

Epigenetic Mechanisms in Allergic Diseases
Session Details

2306

Managing Stinging Insect Allergy in the 21st Century
Session Details

Saturday, March 5, 2016: 10:45 AM-12:00 PM

Convention Center, Level One, Petree Hall C

1.25 CME/CE

Symposium

Moderator:

Dennis K. Ledford , MD FAAAAI

Learning Objectives:

Describe the mechanism of tolerance development during venom immunotherapy
Assess the indications for initiation and discontinuation of venom immunotherapy
Evaluate the overlap between venom-induced anaphylaxis and mast cell disorders

This Session Will Use Audience Response System Technology.

10:45 AM

Mechanism of Tolerance to Venom Induced By Immunotherapy
Cezmi A. Akdis, MD FAAAAI

11:05 AM

Question & Answer

11:10 AM

Initiation and Discontinuation of Venom Immunotherapy: How Long is Enough?
David B.K. Golden, MD FAAAAI

Handouts

2306 Golden.pdf (209.7 kB)

11:30 AM

Question & Answer

11:35 AM

Anaphylaxis after Hymenoptera Sting-Overlap with Mast Cell Disorder
Mariana C. Castells, MD PhD FAAAAI

11:55 AM

Question & Answer

2307

What Do I Do With These Abnormal Newborn Screening Results?
Session Details

Saturday, March 5, 2016: 10:45 AM-12:00 PM

Convention Center, Level Two, Room 502A

1.25 CME/CE

Symposium

Moderator:

Lisa J. Kobrynski , MD MPH FAAAAI

Learning Objectives:

Identify the incidence of SCID and survival outcomes after implementation of newborn screening programs
Identify idiopathic lymphopenia, dilemmas and strategies for management
Discuss various transplantation protocols and new experimental treatment options for SCID

This Session Will Use Audience Response System Technology.

10:45 AM

What Have We Learned So Far?
Vincent R. Bonagura, MD FAAAAI

11:05 AM

Question & Answer

11:10 AM

Not SCID but Not Normal
Kathleen E. Sullivan, MD PhD FAAAAI

Handouts

Not SCID but not normal.pdf (13.8 MB)

11:30 AM

Question & Answer

11:35 AM

Transplantation Options and Novel Therapies
Donald B. Kohn, MD

11:55 AM

Question & Answer

2308

NHLBI's Clinical Asthma Research Network (AsthmaNet)'s Approach to Key Asthma Questions in Children and Adults
Session Details

Saturday, March 5, 2016: 10:45 AM-12:00 PM

Convention Center, Level One, Concourse Hall Room 152

1.25 CME/CE

Symposium

Moderator:

James Kiley , PhD

Learning Objectives:

Discuss individualized long-term controller therapy in toddlers with asthma
Discuss the effect of acetaminophen versus ibuprofen on asthma exacerbations in children with asthma
Discuss the potential role of airway microbiome on the effect of ICS on adult asthma

This Session Will Use Audience Response System Technology.

10:45 AM

Are Inhaled Corticosteroids Superior to Leukotriene Antagonists in Toddlers with Early Asthma?
Daniel J. Jackson, MD

11:05 AM

Question & Answer

11:10 AM

Does Acetaminophen Use Increase Exacerbations in Children with Early Asthma?
William J. Sheehan, MD

11:30 AM

Question & Answer

11:35 AM

Airway and Gut Microbiome an Dphenotypes of Mild Asthma
Homer A. Boushey Jr., MD FAAAAI

11:55 AM

Question & Answer

2311

Allied Health: Comorbidities of Atopic Dermatitis
Session Details

Saturday, March 5, 2016: 10:45 AM-12:00 PM

Convention Center, Level Two, Room 407

1.25 CME/CE

Symposium

Moderator:

Sally A. Noone , RN MSN

Learning Objectives:

Describe the systemic comorbidities associated with atopic dermatitis
Identify the atopic dermatitis patients at highest risk for systemic comorbidities
Discuss treatment considerations for atopic dermatitis and their impact on associated comorbidities

10:45 AM

Sleep Disturbances in Atopic Dermatitis
Anna B. Fishbein, MD, MSCI

11:05 AM

Question & Answer

11:10 AM

Mental Health Comorbidity in Atopic Dermatitis
Jennifer S. LeBovidge, PhD

Handouts

LeBovidge_ADComorbidity_handout.pdf (338.0 kB)

11:30 AM

Question & Answer

11:35 AM

Medical Comorbidities of Atopic Dermatitis
Kelly D. Stone, MD PhD FAAAAI

11:55 AM

Question & Answer

2312

Allied Health: Cutting Edge: Health Related Quality of Life and Allergy Disease
Session Details

Saturday, March 5, 2016: 10:45 AM-12:00 PM

Convention Center, Level Two, Room 409AB

1.25 CME/CE

Symposium

Moderator:

Scott H. Sicherer , MD FAAAAI

Learning Objectives:

Discuss the quality of life implications of various food allergy management approaches (including Oral Immunotherapy)
Identify the role of the dietitian in assisting patients in maintaining or improving quality of life

10:45 AM

Health-Related Quality-of- Life and Food Allergies: What Do We Know?
Matthew J. Greenhawt, MD MBA MSc

Handouts

QoL AAAAI 2016.pdf (1.6 MB)

11:05 AM

Question & Answer

11:10 AM

The Role of the Dietitian in Health-Related Quality-of-Life in Food Allergy: What Can We Do?
Carina Venter, PhD RD

Handouts

QoL What can the dietitian do HANDOUT.pdf (10.7 MB)

11:30 AM

Question & Answer

11:35 AM

How Does Oral Immunotherapy to Food Affect Health-Related Quality-of-Life: What Can We Do?
Paul J. Turner, FRACP PhD

Handouts

OIT and QoL AAAAI 2016 HANDOUT.pdf (7.5 MB)

11:55 AM

Question & Answer

2501

Understanding the Immune Basis of Drug-Induced Skin Reactions TICKETED
Session Details

2502

Epigenetics in Asthma TICKETED
Session Details

2503

Immune Deficiency in CRS: Screening and Treatment TICKETED
Session Details

2504

Learning Hereditary Angioedema by Team Based Learning TICKETED
Session Details

2505

Latex Allergy: An Update for the Clinician TICKETED
Session Details

2506

Airway Epithelium as the interplay Between Type 2 Innate Lymphoid Cells (ILC2) and Th2 Immunity TICKETED
Session Details

2507

Allele-Specific PCR to Diagnose D816V+ Clonal Mast Cell Disorders TICKETED
Session Details

2508

Managing Milk Allergy in Children TICKETED
Session Details

2509

Drug Allergy Challenges in the Office TICKETED
Session Details

2510

Mechanisms of Allergic Inflammation in Omenn Syndrome TICKETED
Session Details

2511

Molecular Allergy Diagnosis: Does it Help in Managing Your Patient With Multiple Environmental and Food Allergies? TICKETED
Session Details

2512

Challenging Cases in Venom Immunotherapy (VIT) TICKETED
Session Details

2551

Rhinovirus is More Important Than RSV in the Origin of Asthma
Session Details

2552

Are You Nuts? Peanuts Should Not be Removed From Schools and Other Public Places
Session Details

2553

Allergen Immunotherapy: Dose Adjustment: Are They Needed for Local Reactions, Peaks of Season, Gaps in Treatment?
Session Details

2554

Imaging Immunity in Health and Disease
Session Details

2555

Maintenance of Certification: Past, Present and Future
Session Details

2611

Allied Health Travel Grant Recipients
Session Details

Saturday, March 5, 2016: 2:00 PM-3:15 PM

Convention Center, Level Two, Room 409AB

1.25 CME/CE

Workshop

Moderator:

Stephen J. McGeady , MD FAAAAI

Learning Objectives:

Discuss activates by Allied Health members which contribute to the overall care of patients

2:00 PM

Common Variable Immune Deficiency (CVID)
Olivia Rae Ackerman, MSN APRN PPCNP-BC

2:05 PM

Food Allergy
Alexia K. Beauregard, MS RD CSP LD

2:10 PM

Driven Inpatient Penicillin Allergy Testing Program
Scott A Tarver, PharmD BCPS

2:15 PM

Question & Answer

2:30 PM

Work Related Asthma
Joshua C. Lipszyc, BA MSc

2:35 PM

Asthma Impact Model for Fresno
Stephani A. Pineda, BSPH

2:40 PM

Georgia Asthma Coalition
Jon Allan Ramsey, RN

2:45 PM

Question & Answer

3:00 PM

Complex Asthma Clinic
Sabrina Jalleh Smith, RN

3:05 PM

Allergic/Asthmatic Reactions in Dental Field
Darshna Yagnik, MS PhD

3:10 PM

Question & Answer

2612

Allied Health: Collecting and Managing Data from an Environmental Home Assessment
Session Details

Saturday, March 5, 2016: 2:00 PM-3:15 PM

Convention Center, Level Two, Room 403A

1.25 CME/CE

Workshop

Moderator:

Susan L. Balcer-Whaley , MPH

Learning Objectives:

Discuss various strategies for collecting environmental home assessments
Identify equipment used for a home assessment
Identify how environmental samples are collected, measured and managed

2:00 PM

Conducting an Environmental Home Assessment
Susan L. Balcer-Whaley, MPH

2:20 PM

Question & Answer

2:25 PM

Tools of the Trade
Michelle Newman, RN

2:45 PM

Question & Answer

2:50 PM

Managing and Measuring Environmental Data
Jean Curtin-Brosnan, MA

3:10 PM

Question & Answer

2701

The Past, Present and Future of Asthma
Session Details

2801

AAP: Hot Topics in Pediatric Allergy TICKETED
Session Details

2802

Vocal Cord Dysfunction (VCD): More Common Than You Think
Session Details

Saturday, March 5, 2016: 4:45 PM-6:00 PM

Convention Center, Level Two, Room 403B

1.25 CME/CE

Workshop

Moderator:

Mark F. Sands , MD FAAAAI

Learning Objectives:

Discuss that VCD exists on a spectrum of airway disorders and is probably under-diagnosed in many patients with severe, difficult-to-control asthma
Discuss a rational approach to VCD diagnosis, including characteristic features in history, physical exam and pulmonary function tests
Describe an approach to VCD management via speech therapy

4:45 PM

Vocal Cord Dysfunction: More Common Than You Think
Stephen A. Tilles, MD FAAAAI

Handouts

Tilles Ayars Ann Allergy 2013 111 342.pdf (384.6 kB)

5:00 PM

Question & Answer

5:10 PM

Practical Approach to VCD Diagnosis: Laryngoscopy and More
Andrej A. Petrov, MD

Handouts

Pittsburgh VCD index.pdf (44.3 kB)

5:25 PM

Question & Answer

5:35 PM

Principles of Speech Therapy in the Management of VCD
Gerriann Jackson, MS, CCC-SLP

5:50 PM

Question & Answer

2803

How Allergic Immune Responses are Initiated and Regulated: The Role of Epithelial Cells and Immune System in Allergic Diseases
Session Details

Saturday, March 5, 2016: 4:45 PM-6:00 PM

Convention Center, Level Two, Room 404AB

1.25 CME/CE

Workshop

Moderator:

Michiko K. Oyoshi , PhD MSc FAAAAI

Learning Objectives:

Describe the role of epithelial cell-derived cytokines in the initiation and amplification of Th-2 immune responses
Describe the relationship of epithelial cell-derived cytokines and allergic responses
Discuss the unique challenges of targeting epithelial cell-derived cytokines in allergic disease

4:45 PM

Friend or Foe: Pathogenic and Protective Roles of Epithelial Cell-Derived Cytokines in Allergic Diseases
Steven Ziegler, PhD

5:00 PM

Question & Answer

5:10 PM

Epithelial Regulation of Allergic Inflammation
David Artis, PhD

5:25 PM

Question & Answer

5:35 PM

Anti-Epithelial Cell-Derived Cytokine Therapies: Basic Mechanisms Underlying the Development of New Therapies
Kari C. Nadeau, MD PhD FAAAAI

5:50 PM

Question & Answer

2804

Adherence Challenges in Asthma: Pediatrics, Adolescents and Older Adults
Session Details

2805

Immune Deficiency Lurking in the Allergy Clinic
Session Details

Saturday, March 5, 2016: 4:45 PM-6:00 PM

Convention Center, Level Two, Room 408A

1.25 CME/CE

Workshop

Moderator:

Seema Sharma Aceves , MD PhD FAAAAI

Learning Objectives:

Distinguish allergy phenotypes from immune deficiencies
Discuss primary immune deficiencies from the lens of a practicing allergist

This Session Will Use Audience Response System Technology.

4:45 PM

Eczema As a Sign of Immune Deficiency
Elena E. Perez, MD PhD FAAAAI

5:00 PM

Question & Answer

5:10 PM

Ruling out Immune Deficiencies in Eosinophilia
Amy D. Klion, MD

Handouts

ARSQ&AFormKlionAAAAI2016.pdf (105.3 kB)

5:25 PM

Question & Answer

5:35 PM

When a High IgE Means More Than a High IgE
Alexandra F. Freeman, MD

5:50 PM

Question & Answer

2806

Chronic Rhinosinusitis in Children
Session Details

Saturday, March 5, 2016: 4:45 PM-6:00 PM

Convention Center, Level Two, Room 408B

1.25 CME/CE

Workshop

Moderator:

Robert M. Naclerio , MD FAAAAI

Learning Objectives:

Discuss aspects of CRS pathophysiology that are relevant to children
Demonstrate particularities of CRS symptoms and clinical presentation in children
Discuss pediatric aspects of medical treatment of CRS, the features, indications and contraindications of sinus surgery in children with CRS

This Session Will Use Audience Response System Technology.

4:45 PM

Clinical Presentation and Pathophysiology of Chronic Rhinosinusitis in Children
Daniel L. Hamilos, MD FAAAAI

5:00 PM

Question & Answer

5:10 PM

Medical Treatment of Rhinosinusitis in Children
David W. Hauswirth, MD FAAAAI

5:25 PM

Question & Answer

5:35 PM

Surgical Options in Children with Chronic Rhinosinusitis
Fuad M. Baroody, MD FAAAAI

5:50 PM

Question & Answer

2807

How Bronchial Smooth Muscle Cells Make Airways Hyper-Responsive
Session Details

2808

Advances in Natural Killer Cell and Natural Killer T Cell Biology
Session Details

2809

Novel Biologicals for Asthma and Allergic Rhinosinusitis
Session Details

Saturday, March 5, 2016: 4:45 PM-6:00 PM

Convention Center, Level Two, Room 502A

1.25 CME/CE

Workshop

Moderator:

Hirohisa Saito , MD PhD FAAAAI

Learning Objectives:

Discuss novel biologicals in allergy and immunology
Discuss mechanisms underlying novel immunologic therapies

4:45 PM

Biologicals in Allergy and Asthma
Sally E. Wenzel, MD FAAAAI

5:00 PM

Question & Answer

5:10 PM

Novel Allergen-Specific Immunotherapies and Biologicals for Allergic Rhinosinusitis
Claus Bachert, MD PhD

Handouts

Biologics JACI 2015.pdf (1.6 MB)

5:25 PM

Question & Answer

5:35 PM

Immunologic Mechanisms of Novel Allergen-Specific Immunotherapies
Cezmi A. Akdis, MD FAAAAI

5:50 PM

Question & Answer

2810

Clinical Implications of Microbiome in Chronic Respiratory Disease
Session Details

Saturday, March 5, 2016: 4:45 PM-6:00 PM

Convention Center, Level Two, Room 502B

1.25 CME/CE

Workshop

Moderator:

Amber U. Luong , MD PhD

Learning Objectives:

Discuss the deep sequencing technology, its limitations and consequences on the understanding of the microbiome, especially the limited understanding of the fungal microbiome
Identify current knowledge of airway microbiota and outline how host-microorganism interactions influence health and disease
Discuss how the microbiota in the mouth and nose influences the microorganism communities in the lungs and implications on disease

4:45 PM

Why is the Fungal Microbiome so Hard to Describe?
David B. Corry, MD

5:00 PM

Question & Answer

5:10 PM

Host-Microorganism Interactions in Chronic Respiratory Disease
Yvonne Huang, MD

5:25 PM

Question & Answer

5:35 PM

Relationship of the Upper and Lower Respiratory Tract Microbiome
Gary Huffnagle, PhD

Handouts

AAAAI 2016 handout-Huffnagle.pdf (9.4 MB)

5:50 PM

Question & Answer

2811

ABAI: How to Use the ABAI WebPortal for Maintenance of Certification (MOC) Activities TICKETED
Session Details

2812

A Comparison of HAE Guidelines: What's New? TICKETED
Session Details

2813

NSAID-Exacerbated Respiratory Disease (NERD)
Session Details

2814

Problem-Based Learning: Doctor, Can You Prevent My Baby from Developing Peanut Allergy? TICKETED
Session Details

2815

When Writing a Script Just Isn't Enough: Strategies to Overcome Barriers Associated with Poor Asthma Control in Older Adults
Session Details

Saturday, March 5, 2016: 4:45 PM-6:00 PM

Convention Center, Level One, Concourse Hall Room 152

1.25 CME/CE

Workshop

Moderator:

Alan P. Baptist , MD MPH FAAAAI

Learning Objectives:

Describe diagnostic and therapeutic approaches to the elderly asthmatic
Describe the effect of financial concerns and medication related side-effects on asthma management in the elderly
Explain how non-pharmaceutical interventions including pulmonary rehabilitation impact the elderly asthmatic

4:45 PM

Diagnostic and Management Approaches for Asthma in Older Adults with Significant Co-Morbidities
Tolly Epstein, MD MS FAAAAI

Handouts

2815 Workshop Epstein.pdf (428.4 kB)

5:00 PM

Question & Answer

5:10 PM

Non-Medication Approaches to Improve Asthma Control in Older Adults
Carol A. Saltoun, MD FAAAAI

5:25 PM

Question & Answer

5:35 PM

Developing Shared Goals for Asthma Management in Older Adults: Acknowledging the Impact of Financial Concerns and Medication-Related Side Effects
Dennis K. Ledford, MD FAAAAI

5:50 PM

Question & Answer

2816

FIT Workshop: Interesting Cases Part 1
Session Details

Saturday, March 5, 2016: 4:45 PM-6:00 PM

JW Marriott, Platinum Ballroom Level, Salon C

1.25 CME/CE

Workshop

Primary Moderators:

T. Prescott Atkinson , MD PhD FAAAAI
Katherine E. Gundling , MD

Learning Objectives:

Evaluate the management of challenging patient cases by trainees in allergy/imunology
Compare and contrast management strategies for challenging patient cases with peers

4:45 PM

Unanticipated Immune Complications from Tumor Immunotherapy
Bharat Kumar, MD

5:00 PM

CNS Histoplasmosis in an Adult with Idiopathic CD4+ T-Lymphocytopenia (ICL)
Anar Dossumbekova, MD

5:15 PM

Warts and Small Stature - Indications of Considering Underlying Immunodeficiency
Jacqueline Eastman, MD

5:30 PM

An Infant with Absent T Cells, Fevers and Proliferation of Oligoclonal "Rogue" T Cell Population
Eric M. Schauberger, DO PhD

Handouts

Schauberger_OligoclonalTcellExpansion_3 4 16.pdf (291.3 kB)

5:45 PM

Abnormal New Born Screening in a Patient with CHARGE Syndrome
Britta Sundquist, MD

2821

Allied Health: What Allied Health Professionals Need to Know about Drug Sensitivity
Session Details

2822

Allied Health: Skin Testing: Getting to the Point TICKETED
Session Details

3001

Mast Cell Activation Syndrome(s): Diagnosis and Treatment TICKETED
Session Details

3002

Eosinophil Cytolysis: Programmed Death Pathways and Significance in Disease TICKETED
Session Details

3003

Chronic Rhinosinusitis: The Evidence Base for Current Treatments TICKETED
Session Details

3004

Chronic Rhinosinusitis in Children TICKETED
Session Details

3005

Recurrent Infection in Adults TICKETED
Session Details

3006

Exercise-Induced Anaphylaxis: Food-Dependent and -Independent TICKETED
Session Details

3007

Helpful Advice in Improving Asthma Adherence TICKETED
Session Details

3008

Mold: Facts & Fiction TICKETED
Session Details

3009

When Do You Give SLIT vs. SCIT? TICKETED
Session Details

3010

Nasal Allergen Provocation Test: A Real Challenge TICKETED
Session Details

3011

Challenges in the Diagnosis and Treatment of Exercise-Induced Bronchoconstriction (EIB) TICKETED
Session Details

3012

AERD: More Than Asthma TICKETED
Session Details

3013

Gene Therapy as a Treatment of Primary Immune Defects TICKETED
Session Details

3021

Allied Health: Tips and Tricks on Starting and Managing a Research Center TICKETED
Session Details

3022

Allied Health: Lessons Learned from a Multidisciplinary Eosinophilic Esophagitis Clinic TICKETED
Session Details

3050

Are LABAs Safe in Asthma? Are They Effective?
Session Details

3301

EAACI: Managing Allergy at the Frontline
Session Details

Sunday, March 6, 2016: 10:45 AM-12:00 PM

Convention Center, Level One, Petree Hall C

1.25 CME/CE

Symposium

Primary Moderators:

Maria Antonella Muraro , MD PhD
Ioana O. Agache , CME

Learning Objectives:

Discuss the role of PI-3 kinase defects in viral susceptibilit
Discuss presentations and causes of NK cell deficiency
Identify defects in innate immune function that lead to severe influenza infections

10:45 AM

Anaphylaxis Severity Score: Towards a Harmonized Approach?
Maria Antonella Muraro, MD PhD

11:05 AM

Question & Answer

11:10 AM

Molecular Diagnosis: How to Move Forward? Diagnostic Algorithms and Beyond
Carsten Bindslev-Jensen, MD PhD DMSci FAAAAI

11:30 AM

Question & Answer

11:35 AM

Allergen-Specific Immunotherapy: Dealing with Personalized Medicine
Marek Jutel, MD PhD

11:55 AM

Question & Answer

3302

T Cell Determination Heterogeneity and Hijacking in Allergic Disease
Session Details

Sunday, March 6, 2016: 10:45 AM-12:00 PM

Convention Center, Level One, Petree Hall D

1.25 CME/CE

Symposium

Moderator:

David D. Chaplin , MD PhD FAAAAI

Learning Objectives:

Recognize unique functions of memory T Cells in allergic disease
Identify the extent of plasticity in differentiated T Cell lineages and implications in allergic disease
Identify heterogeneity of T Cell differentiation pathways and implications in allergic disease

10:45 AM

IL-2-Dependent Tissue-Resident Th2 Memory Cells Drive Asthma
Marion Pepper, PhD

11:05 AM

Question & Answer

11:10 AM

Reprogramming of T Regulatory Cells In Allergic Disease
Talal A. Chatila, MD MSc

11:30 AM

Question & Answer

11:35 AM

Novel Pathways for Th9 Cell Development and Allergic Lung Disease
Richard Siegel, MD PhD

11:55 AM

Question & Answer

3303

Difficult Viral Infections Due to Defects in Innate Immunity
Session Details

Sunday, March 6, 2016: 10:45 AM-12:00 PM

Convention Center, Level Two, Theatre (Room 411)

1.25 CME/CE

Symposium

Moderator:

Lisa R. Forbes , MD

Learning Objectives:

Discuss the role of PI-3 kinase defects in viral susceptibility
Discuss presentations and causes of NK cell deficiency
Identify defects in innate immune function that lead to severe influenza infections

10:45 AM

Innate Immune Control of Influenza
Grant Schulert, MD PhD

11:05 AM

Question & Answer

11:10 AM

Defects in the PI-3 Kinase Signaling Pathway
Carrie L. Lucas, PhD

11:30 AM

Question & Answer

11:35 AM

NK Cell Deficiency
Emily Mace, PhD

11:55 AM

Question & Answer

3304

Emerging and Current Diagnostics and Therapies for Eosinophilic Esophagitis
Session Details

3305

Severe Asthma in Children: From Mechanisms to Disease Modification
Session Details

Sunday, March 6, 2016: 10:45 AM-12:00 PM

Convention Center, Level Two, Room 408B

1.25 CME/CE

Symposium

Moderator:

To be announced.

Learning Objectives:

Describe the frequency and common features of severe asthma in children
Identify common underlying mechanisms of severe asthma in children
Discuss the efficacy of omalizumab and the potential for disease modification in children

This Session Will Use Audience Response System Technology.

10:45 AM

Asthma Epidemiology and Alternate Diagnoses to Consider
Theresa W. Guilbert, MD MS

Handouts

AAAAI 2016 severe asthma epi DDX handout.pdf (3.5 MB)

11:05 AM

Question & Answer

11:10 AM

Mechanisms of Severe Asthma in Children
Leonard B. Bacharier, MD FAAAAI

11:30 AM

Question & Answer

11:35 AM

The Role of Biologic Therapies: Are There Opportunities for Disease Modification?
Daniel J. Jackson, MD

11:55 AM

Question & Answer

3306

Using SCIT vs. SLIT to Modify Allergic Disease
Session Details

Sunday, March 6, 2016: 10:45 AM-12:00 PM

Convention Center, Level Two, Room 502A

1.25 CME/CE

Symposium

Moderator:

Linda Cox , MD FAAAAI

Learning Objectives:

Discuss the latest data on the efficacy and safety of SCIT compared to SLIT for grass pollen allergy
Identify several newly discovered biomarkers for AIT efficacy
Discuss and explain safety and adherence issues of SLIT and SCIT and utilize resources to try to overcome them

10:45 AM

SCIT vs. SLIT: Efficacy in Clinical Trials
Stephen R. Durham, MA MD FRCP

Handouts

Durham SR JACI Feb 2016 SLIT v SCIT review.pdf (911.9 kB)

11:05 AM

Question & Answer

11:10 AM

Nasal and Systemic Biomarkers for Immunotherapy Efficacy: Lessons Learned from the SLIT-SCIT Trial
Mohamed H. Shamji, PhD FAAAAI

11:30 AM

Question & Answer

11:35 AM

SLIT-SCIT Safety and Adherence: Do They Matter?
Giovanni Passalacqua, MD

Handouts

LOSANGELES2016-hand.pdf (2.8 MB)

11:55 AM

Question & Answer

3307

New Strategies for the Prevention of Allergic Diseases
Session Details

3311

Allied Health: Determining the Bioequivalence of Generic Inhalers
Session Details

Sunday, March 6, 2016: 10:45 AM-12:00 PM

Convention Center, Level Two, Room 406AB

1.25 CME/CE

Symposium

Moderator:

Anne E. Borgmeyer , DNP RN CPNP AE-C

Learning Objectives:

Identify the differences in regulatory requirements for inhalers
Discuss the different methods of determining bioavailability of inhalers
Describe the pharmacokinetic studies of inhalers

10:45 AM

Use of Methacholine Challenge to Determine Bioequivalence of Beta Agonist Inhalers
Leslie Hendeles, PharmD

Handouts

AAAAI-2016.pdf (1015.5 kB)

11:05 AM

Question & Answer

11:10 AM

FDA Requirements
Gunther Hochhaus, PhD

11:30 AM

Question & Answer

11:35 AM

Pharmacokinetics of Inhaled Drugs
Gunther Hochhaus, PhD

11:55 AM

Question & Answer

3312

Allied Health: Advocacy for Patients with Primary Immune Deficiency Disease (PIDD)
Session Details

Sunday, March 6, 2016: 10:45 AM-12:00 PM

Convention Center, Level Two, Room 409AB

1.25 CME/CE

Symposium

Moderator:

Stephen J. McGeady , MD FAAAAI

Learning Objectives:

Discuss the approaches to use to assist PIDD patients to be a self-advocate
Discuss techniques to support patients to manage the challenges of living with a chronic illness

10:45 AM

Advocacy for Patients with Primary Immune Deficiency Disease (PIDD): Assuming the Reins of Clinical Care
Carla M. Duff, CPNP MSN CCRP IgCN

11:05 AM

Question & Answer

11:10 AM

Advocacy for Patients with Primary Immune Deficiency Disease (PIDD): Advocacy for Life
William R. Blouin, MSN ARNP CPNP

11:30 AM

Question & Answer

11:35 AM

Strategies to Develop and Advocate Positive Relationships Between the Patient, Provider and Payer
Debbie Manning, RN BSN IgCN

11:55 AM

Question & Answer

3501

Rhinolaryngoscopy Case Presentations TICKETED
Session Details

3502

The Microbiome and Food Allergy TICKETED
Session Details

3503

Newborn Screening for SCID: What Every Clinician Should Know TICKETED
Session Details

3504

Allergenic Components: The Clinical Application TICKETED
Session Details

3505

Inflammasomes in Inflammatory Diseases TICKETED
Session Details

3506

Mastocytosis in the Young Child: Diagnosis, Management and Prognosis TICKETED
Session Details

3507

Approach to Rhinitis in Older Adults TICKETED
Session Details

3508

Rethinking Corticosteroid Safety Based on Growth Studies in Children with Asthma TICKETED
Session Details

3509

Urticaria: Beyond Antihistamines and Omalizumab TICKETED
Session Details

3510

What's New in Chronic Cough? TICKETED
Session Details

3511

Novel Approaches for Smoking Cessation and Tobacco Harm Reduction: Do E-Cigarettes Have a Role? TICKETED
Session Details

3512

Sleep Disordered Breathing (SDB) and its Relation to Allergy TICKETED
Session Details

3521

Allied Health: Psychosocial Assessment and Intervention with Pediatric Asthma Patients TICKETED
Session Details

3522

Allied Health: Ayurvedic Approaches to the Diagnosis, Understanding and Treatment of Allergy, Asthma and Immunology TICKETED
Session Details

3551

Eosinophilic Esophagitis: A Primary Disease of the Esophageal Mucosa
Session Details

3552

Skin Testing is Necessary Before Early Introduction of Peanut for Prevention of Peanut Allergy TICKETED
Session Details

3553

Should Antibiotic Prophylaxis Be Routinely Used in Patients With Antibody-Mediated Primary Immunodeficiency?
Session Details

3554

Allied Health: Allergen Immunotherapy in the Hospital and Community Setting
Session Details

3555

FIT Workshop: Interesting Cases Part 2
Session Details

Sunday, March 6, 2016: 12:30 PM-1:45 PM

Convention Center, Level Two, Room 403A

1.25 CME/CE

Workshop

Primary Moderators:

Kelly D. Stone , MD PhD FAAAAI
Paul J. Dowling , MD FAAAAI

Learning Objectives:

Evaluate the management of challenging patient cases by trainees in allergy/immunology
Compare and contrast management strategies for challenging patient cases with peers

12:30 PM

Schnitzler Syndrome
Sultan Alandijani, MD

12:45 PM

Orofacial Granulomatosis Masquerading As "Angioedema"
Chen Hsing Lin

1:00 PM

All That Is Red and Bumpy Is Not Eczema
Schweta Arakali, MD

1:15 PM

Hemothorax Associated with Status Asthmaticus
Peter Ricketti, DO

1:30 PM

Recurrent Anaphylaxis to Cat, or Is It?
Jay Jin, MD PhD

3701

ADT: Asthma Endotypes: What are the Therapeutic Implications?
Session Details

3702

BCI: Traffic Pollution Exposure and Allergic Disease: New Insights
Session Details

3703

EORD: Importance of School Environments for Children with Asthma
Session Details

3704

FADDA: Novel IgE-Independent Pathways for Drug Reactions
Session Details

3705

HEDQ: Teleallergy: The Use of Technology to Enhance Practice and Research in Allergy/Immunology
Session Details

3706

IRSO: SLIT and SCIT: Alternatives or Rivals?
Session Details

3707

MAAI: Mechanistic Dissection of IgG4-Related Disease
Session Details

4001

Practical Approach to Infants with Abnormal SCID Newborn Screening Results TICKETED
Session Details

4002

Review and Discussion of Fungus Health Effects TICKETED
Session Details

4003

Improving Compliance and Retention of Patients of Varied Cultural Backgrounds TICKETED
Session Details

4004

How to Write a Manuscript and an IRB Protocol TICKETED
Session Details

4005

A Successful Approach to Food Allergy Diagnostic Dilemmas TICKETED
Session Details

4006

Asthma in the Older Adult TICKETED
Session Details

4007

Anti-Eosinophil Biologic Therapies in Allergic Diseases TICKETED
Session Details

4008

CD34^⁺Cells: Naive but Not Innocent Players of Allergic Inflammation TICKETED
Session Details

4009

Optimal SCIT Prescribing Using Optimal Dosing TICKETED
Session Details

4010

Office-Based Clinical Teaching of Residents and Students TICKETED
Session Details

4011

Work-Exacerbated Asthma TICKETED
Session Details

4150

Allied Health: Association of Asthma Educators: Becoming an Asthma Educator and Care Manager TICKETED
Session Details

Monday, March 7, 2016: 9:00 AM-4:00 PM

Convention Center, Level Two, Room 407

6.00 CME/CE

Course

Learning Objectives:

Describe the burden of asthma in the United States
Describe key components of asthma management from EPR-3
Identify and evaluate patients' and caregivers' educational needs and select management tools to optimize partnerships in care

9:00 AM

Becoming an Asthma Educator and Care Manager
Maureen George, PhD RN AE-C

9:45 AM

Assessment and Monitoring
Dewey F. Hahlbohm, PA-C AE-C

10:30 AM

Break

10:45 AM

Controlling Environmental Factors Contributing to Asthma
Dewey F. Hahlbohm, PA-C AE-C

11:45 AM

Medications
Maureen George, PhD RN AE-C

12:45 PM

Lunch on Your Own

1:15 PM

Inhalation Devices
Dewey F. Hahlbohm, PA-C AE-C

2:15 PM

Education for Partnership in Care
Maureen George, PhD RN AE-C

3:00 PM

Break

3:15 PM

Case Studies/Evaluation
Maureen George, PhD RN AE-C

4301

Novel Endotypes of Asthma: Lessons from the AADCRC
Session Details

Monday, March 7, 2016: 10:45 AM-12:00 PM

Convention Center, Level One, Petree Hall C

1.25 CME/CE

Symposium

Moderator:

John V. Fahy , MD

Learning Objectives:

Describe Th2 High asthma phenotype and treatment
Describe presentation and management of AERD
Discuss the role of pollution in asthma pathogenesis, from mechanism to management

This Session Will Use Audience Response System Technology.

10:45 AM

Aspirin-Exacerbated Respiratory Disease
Tanya M. Laidlaw, MD FAAAAI

11:05 AM

Question & Answer

11:10 AM

Pollution-Induced Asthma
Eric B. Brandt, PhD FAAAAI

Handouts

AAAAI handouts (Eric Brandt).pptx.pdf (29.5 MB)

11:30 AM

Question & Answer

11:35 AM

Allergic “Th2 High” Asthma
Prescott Woodruff, MD MPH

11:55 AM

Question & Answer

4302

Environmental and Lifestyle Influences on Childhood Asthma
Session Details

Monday, March 7, 2016: 10:45 AM-12:00 PM

Convention Center, Level One, Petree Hall D

1.25 CME/CE

Symposium

Moderator:

Gang Dong , MD PhD

Learning Objectives:

List the factors contributing to asthma development in pre-schoolers
Describe the immunologic basis for early life sensitization which increases asthma risk
Describe microbiome-virus interrelationships in asthma and strategies for asthma prevention in childhood

10:45 AM

Preschool Exposures That Influence the Development of Asthma
Leonard B. Bacharier, MD FAAAAI

11:05 AM

Question & Answer

11:10 AM

Immunologic Correlates of Multiple Early Sensitization Progressing to Childhood Asthma
Matthew C. Altman, MD

11:30 AM

Question & Answer

11:35 AM

Microbiome Effects on Frequency of Viral Infection and Virus-Induced Exacerbations of Asthma
Daniel J. Jackson, MD

11:55 AM

Question & Answer

4303

State-of-the-Art: Update from the AADCRC Food Allergy Research Centers
Session Details

Monday, March 7, 2016: 10:45 AM-12:00 PM

Convention Center, Level Two, Room 404AB

1.25 CME/CE

Symposium

Moderator:

Brian P. Vickery , MD FAAAAI

Learning Objectives:

Describe the T Cell responses during food immunotherapy
Describe the approaches to profiling food allergic processes
Describe the B and T lymphocyte surrogates of tolerance

10:45 AM

Mechanistic Studies in T Cells During Food Allergen Immunotherapy
Kari C. Nadeau, MD PhD FAAAAI

11:05 AM

Question & Answer

11:10 AM

Microengaving-Based Profiling of Human Food Allergic Immune Processes
Erik R. Wambre, PhD MBE

11:30 AM

Question & Answer

11:35 AM

Surrogates of Persistent Tolerance Among the T and B Lymphocyte Antigen-Specific Responses During Peanut Oral Immunotherapy
Wayne Shreffler, MD PhD FAAAAI

11:55 AM

Question & Answer

4304

Phospholipases A₂ and Lipid Mediators in the Pathogenesis of Asthma
Session Details

Monday, March 7, 2016: 10:45 AM-12:00 PM

Convention Center, Level Two, Room 406AB

1.25 CME/CE

Symposium

Moderator:

Joshua A. Boyce , MD FAAAAI

Learning Objectives:

Describe how lipids are major mediators of asthma
Discuss the role of phospholipases A₂, enzymes for the generation of lipids
Describe the role of innate immune cells that produce these enzymes and initiate asthma pathogenesis in humans

10:45 AM

Role of Group X sPLA2 and Epithelial Cells in Asthma
Teal S. Hallstrand, MD MPH

Handouts

Hallstrand sPLA2 Group X AAAAI 2016.pdf (3.4 MB)

11:05 AM

Question & Answer

11:10 AM

Role of Group V sPLA2 and Macrophages in Asthma
Barbara Balestrieri, MD

11:30 AM

Question & Answer

11:35 AM

Influence of Human Genetic Variation on the Biosynthesis, Metabolism and Impact of Arachidonic Acid in Inflammatory Processes
Floyd H. Chilton, PhD

11:55 AM

Question & Answer

4305

Immunologic Insights into Environmental Triggers of Asthma
Session Details

4306

Allergen Immunotherapy: From Mechanisms to Biomarkers
Session Details

Monday, March 7, 2016: 10:45 AM-12:00 PM

Convention Center, Level Two, Room 408B

1.25 CME/CE

Symposium

Moderator:

Stephen R. Durham , MA MD FRCP

Learning Objectives:

Describe novel local and systemic responses following allergen immunotherapy
Discuss how Th2A cells can be used to monitor tolerance induction during allergen immunotherapy
Discuss how molecular allergology can be utilized to select patients and monitor the effects allergen immunotherapy

10:45 AM

Mechanisms of Allergen Specific Immunotherapy: What's New?
Mohamed H. Shamji, PhD FAAAAI

11:05 AM

Question & Answer

11:10 AM

Novel Biomarkers for Monitoring AIT
William W. Kwok, PhD

11:30 AM

Question & Answer

11:35 AM

Use of Molecular Allergology to Monitor AIT: Are We There Yet?
Rudolf Valenta, MD

11:55 AM

Question & Answer

4307

Surviving and Optimizing ICD-10
Session Details

Monday, March 7, 2016: 10:45 AM-12:00 PM

Convention Center, Level Two, Room 502A

1.25 CME/CE

Symposium

Moderator:

Melinda M. Rathkopf , MD FAAAAI

Learning Objectives:

Discuss the update on ICD-10 and its impact since the October 2015 go live date
Discuss common problems and identify strategies to optimize ICD-10 in clinical practice
Discuss difficult coding cases from attendees own clinical practices

10:45 AM

Overview and Impact of ICD-10 Since Going Live: Common Problems
Teresa Thompson, CPC CMSCS CCC

Handouts

Surviving and Optimizing ICD-102016.pdf (2.2 MB)

11:05 AM

Question & Answer

11:10 AM

Strategies for ICD-10 Simplification and Optimization
A. Sean McKnight, MD FAAAAI

11:30 AM

Question & Answer

11:35 AM

Panel Discussion: ICD-10 Cases: How to Code the Difficult Cases

Panelist
Teresa Thompson, CPC CMSCS CCC

Panelist
A. Sean McKnight, MD FAAAAI

4308

The Spectrum of Angioedema: Bench to Bedside
Session Details

Monday, March 7, 2016: 10:45 AM-12:00 PM

Convention Center, Level Two, Room 502B

1.25 CME/CE

Symposium

Moderator:

Paula J. Busse , MD FAAAAI

Learning Objectives:

Discuss the mechanisms of angioedema in nonhistaminergic angioedema including mediators such as histamine, leukotrienes and bradykinin
Discuss the mechanism of angioedema with NSIADS

This Session Will Use Audience Response System Technology.

10:45 AM

Pathophysiology of Angioedema: Role of Histamine, Leukotrienes and Bradykinin
Bruce L. Zuraw, MD

11:05 AM

Question & Answer

11:10 AM

Bradykinin-Induced Angioedema (ACE-I, HAE, AAE): Evaluation and Management
Aleena Banerji, MD

11:30 AM

Question & Answer

11:35 AM

NSAIDs-Induced Angioedema: Pathophysiology, Evaluation and Management
Rebecca Saff, MD PhD

11:55 AM

Question & Answer

4701

There's an App for That: iPhone/iPad, Android and Web Tools for Clinical Practice TICKETED
Session Details

4702

Oral Immunotherapy for Food Allergy TICKETED
Session Details

4703

So the Patient Has Eosinophilia: What Next? TICKETED
Session Details

4704

State-of-the-Art: Understanding the Genetics of CVID: Bench to Bedside TICKETED
Session Details

4705

Evaluation and Management of the Difficult-to-Treat Rhinitis Patient TICKETED
Session Details

4706

Mastocytosis Mimics: Cutting Through the Clutter TICKETED
Session Details

4707

Approaching the Pediatric Patient with Recurrent Infections TICKETED
Session Details

4708

Dysregulation Coagulation System in Airway Inflammation and Remodeling TICKETED
Session Details

4709

Bacterial Influence on Asthma TICKETED
Session Details

4710

Mouse Models of Asthma, Food Allergy and Skin Disease TICKETED
Session Details

4752

CANCELLED Rhinitis Guidelines Around the Globe: The Differences in the U.S. Practice Parameters on Rhinitis Translate into Better Clinical Applicability Than the ARIA 2015 and Integrated Care Pathways TICKETED
Session Details

4801

Update from the U.S. Food and Drug Administration (FDA)
Session Details

Monday, March 7, 2016: 4:45 PM-6:00 PM

Convention Center, Level Two, Room 403A

1.25 CME/CE

Workshop

Moderator:

Jay E. Slater , MD

Learning Objectives:

Identify recent issues of scientific importance at the FDA and their clinical implications
Discuss and recognize new data regarding potential treatment options in severe asthma
Discuss issues regarding perioperative drug allergy and its clinical implications

4:45 PM

Year-in-Review: An Update from the U.S. Food and Drug Administration
Badrul A. Chowdhury, MD PhD FAAAAI

5:00 PM

Question & Answer

5:10 PM

Development of New Treatments in Severe Asthma
Sofia Chaudhry, MD

5:25 PM

Question & Answer

5:35 PM

Perioperative Drug Allergy
Erika Torjusen, MD

5:50 PM

Question & Answer

4802

Advocacy: A Success Story
Session Details

Monday, March 7, 2016: 4:45 PM-6:00 PM

Convention Center, Level Two, Room 403B

1.25 CME/CE

Workshop

Moderator:

Theodore M. Freeman , MD FAAAAI

Learning Objectives:

Discuss and outline the useful tactics for advocacy
Discuss and critique advocacy efforts

4:45 PM

Unassigned Epinephrine: The Federal Effort
Lynn Morrison

4:55 PM

Question & Answer

5:02 PM

Legislation in Florida
Miguel J. Lanz, MD FAAAAI

5:12 PM

Question & Answer

5:19 PM

Legislation in Texas
Wesley W. Stafford, MD FAAAAI

5:29 PM

Question & Answer

5:36 PM

How to Advocate
Emily Graham, RHIA CCS-P

5:51 PM

Question & Answer

4803

New Biological Therapies on the Horizon for Severe Allergic Diseases of the Airways and Skin
Session Details

4804

Oral Food Challenges in the Office: Opportunities for Early Introduction of Native and Heated Food Proteins to Prevent Food Allergy and Accelerate Tolerance Development
Session Details

Monday, March 7, 2016: 4:45 PM-6:00 PM

Convention Center, Level One, Petree Hall D

1.25 CME/CE

Workshop

Moderator:

Anna H. Nowak-Wegrzyn , MD FAAAAI

Learning Objectives:

Describe the rationale for selecting patients for oral food challenges and the criteria for implementation of safety and monitoring
Describe how to conduct baked milk and egg challenges
Describe how to conduct oral food challenges to peanut in infants

4:45 PM

Who, Where and How to Challenge?
S. Allan Bock, MD FAAAAI

Handouts

Food challenges who where and how - Copy.pdf (727.8 kB)

5:00 PM

Question & Answer

5:10 PM

Special Considerations for Challenges in Infants and Adults
J. Andrew Bird, MD, FAAAAI

Handouts

OFC Considerations handouts.pdf (5.6 MB)

5:25 PM

Question & Answer

5:35 PM

Baked Milk and Egg Challenges
Stephanie A. Leonard, MD

Handouts

AAAAI 2016_4804 Baked Milk and Egg Challenges_Handout_Leonard.pdf (133.0 kB)

5:50 PM

Question & Answer

4805

Experimental Models of Allergic Rhinitis: Evaluation and Utilization
Session Details

4806

Clinical Quality Measures for Allergy/Immunology
Session Details

Monday, March 7, 2016: 4:45 PM-6:00 PM

Convention Center, Level Two, Room 408B

1.25 CME/CE

Workshop

Moderator:

Kaiser G. Lim , MD FAAAAI

Learning Objectives:

Discuss how the Affordable Care Act will impact clinical practice reimbursement
Discuss how process measures, outcomes measures and evidence-based guidelines implementation will impact clinical practice
Discuss how the AAAAI Qualified Clinical Data Registry may benefit your clinical practice

4:45 PM

The Affordable Care Act: Changing from Volume-Based to Value-Based Reimbursement
John Oppenheimer, MD FAAAAI

Handouts

outcomes-final1(1).pdf (1.1 MB)

5:00 PM

Question & Answer

5:10 PM

Process Measures, Outcomes Measures and Evidence Based Guidelines
David M. Lang, MD FAAAAI

Handouts

QualityMeasuresHODLang.pdf (12.3 MB)

5:25 PM

Question & Answer

5:35 PM

The AAAAI Qualified Clinical Data Registry
Linda Cox, MD FAAAAI

5:50 PM

Question & Answer

4807

T Cell Plasticity and Functional Impact on Allergic Diseases
Session Details

Monday, March 7, 2016: 4:45 PM-6:00 PM

Convention Center, Level Two, Room 409AB

1.25 CME/CE

Workshop

Moderator:

Larry Borish , MD FAAAAI

Learning Objectives:

Discuss the role of GATA3 in regulatory T Cell function and its role in therapeutics
Describe the commitment of CD4 T Cells to specific lineages
Describe the heterogeneity and inter-convertibility of T Cell lineages

4:45 PM

Regulatory Affairs of GATA3
Elizabeth Wohlfert, PhD

5:00 PM

Question & Answer

5:10 PM

T Cell Lineage Commitment and Specification
Kiyoshi Hirahara, MD PhD

Handouts

Handout_4807_Kiyoshi Hirahara.pdf (1.8 MB)

5:25 PM

Question & Answer

5:35 PM

Th2 Lineage Heterogeneity
Calman Prussin, MD FAAAAI

5:50 PM

Question & Answer

4808

Autologous Correction of Primary Immunodeficiency Diseases
Session Details

Monday, March 7, 2016: 4:45 PM-6:00 PM

Convention Center, Level Two, Theatre (Room 411)

1.25 CME/CE

Workshop

Moderator:

Troy R. Torgerson , MD PhD

Learning Objectives:

Discuss current progress in gene therapy trials for primary immunodeficiency diseases
Discuss potential uses of induced pluripotent stem cells for both diagnosis and treatment of primary immunodeficiency diseases
Describe the Cas9/CRISPR system and potential methods for site-specific correction of genetic defects in autologous cells

4:45 PM

Update on Gene Therapy
Harry L. Malech, MD

Handouts

Malech - Update on Gene Therapy for PIDs - all files - presentation - annotated references - editorial review.pdf (446.2 kB)

5:00 PM

Question & Answer

5:10 PM

Potential Applications for Induced-Pluripotent Stem Cells
Katja G. Weinacht, MD PhD

5:25 PM

Question & Answer

5:35 PM

Novel Tools for Gene Editing
Caroline Y. Kuo, MD

5:50 PM

Question & Answer

4809

Indoor Air Pollution: New Risks and Health Effects
Session Details

Monday, March 7, 2016: 4:45 PM-6:00 PM

Convention Center, Level Two, Room 502A

1.25 CME/CE

Workshop

Primary Moderators:

Kent Pinkerton , PhD
Mark R. Windt , MD

Learning Objectives:

Discuss the current worldwide trends and impacts of pollution
Discuss the association between damp buildings and respiratory disease
Discuss and list possible new health effects from nanotechnology and manufacturing

4:45 PM

Environmental and Biological Impact of Nanoparticles and Manufacturing
Kent Pinkerton, PhD

5:00 PM

Question & Answer

5:10 PM

Indoor Air Pollution in the Developing World
William J Martin II, MD

5:25 PM

Question & Answer

5:35 PM

Respiratory Health Risks of Indoor Dampness
Mark J Mendell, PhD

Handouts

AAAAI-DMH-talk-Handout.pdf (586.2 kB)

5:50 PM

Question & Answer

4810

Sensitization to Food Allergens: Role of the Adaptive and Innate Immune System
Session Details

Monday, March 7, 2016: 4:45 PM-6:00 PM

Convention Center, Level Two, Room 502B

1.25 CME/CE

Workshop

Moderator:

Jonathan M. Spergel , MD PhD FAAAAI

Learning Objectives:

Describe the role of T Cells in specific allergen sensitization and tolerance
Describe how skin and epithelium may favor sensitization to major allergens
Describe the role of innate immune cells (iNKT cells, basophils) in specific food allergy development

4:45 PM

T Cell Response to Food Allergens: A Fine Balance Between Tolerance and Allergy
Cecilia Berin, PhD

5:00 PM

Question & Answer

5:10 PM

Sensitization Through the Skin: Relevance to Disease Pathogenesis
Sara Brown, MBChB MD

5:25 PM

Question & Answer

5:35 PM

Innate Immune Cells and Sensitization to Specific Allergens: Lessons Learned From Eosinophilic Esophagitis
Antonella Cianferoni, MD PhD FAAAAI

5:50 PM

Question & Answer

4811

Siglecs in Immunity and Inflammation
Session Details

Monday, March 7, 2016: 4:45 PM-6:00 PM

Convention Center, Level Two, Room 503

1.25 CME/CE

Workshop

Moderator:

Nives Zimmermann , MD FAAAAI

Learning Objectives:

Describe the role of glycosylated proteins in immune responses
Discuss the role of siglecs in tumor immunity
Discuss how siglecs control mucosal inflammation

4:45 PM

Role of Sialoadhesin in Immune Responses
James C. Paulson, PhD

5:00 PM

Question & Answer

5:10 PM

Siglecs and Tumor Immunity
Ajit P. Varki, MD

5:25 PM

Question & Answer

5:35 PM

Siglecs and Control of Mucosal Inflammation
Bruce S. Bochner, MD FAAAAI

Handouts

Bochner AAAAI Siglecs and mucosal inflammation 2016v2.pdf (15.4 MB)

5:50 PM

Question & Answer

4812

Viral Infection and Innate Immune Modulation: Implications for Allergy and Asthma
Session Details

Monday, March 7, 2016: 4:45 PM-6:00 PM

Convention Center, Level Two, Room 515A

1.25 CME/CE

Workshop

Moderator:

Mitchell H. Grayson , MD FAAAAI

Learning Objectives:

Discuss how viruses can alter innate immune responses
Describe the differences in innate immune responses between individuals and their effects on antiviral responses
Discuss how alterations of innate immunity affect the development of antiviral adaptive immune responses

4:45 PM

Viral Alteration of the Innate Immune System
Michael Teng, PhD

5:00 PM

Question & Answer

5:10 PM

Host Factor Variability in Response to Viral Infection
Allan Brasier, MD

5:25 PM

Question & Answer

5:35 PM

Innate Immune Dysfunction and the Development of Antiviral Adaptive Immunity
R. Stokes Peebles Jr., MD FAAAAI

Handouts

Innate Immune Dysfunction and the Development of Antiviral Adaptive Immunity AAAAI.Peebles handout pdf.pdf (420.0 kB)

5:50 PM

Question & Answer

4813

How to Present Like a Pro and Make It Look Easy: Engaging the 21st Century Audience
Session Details

Monday, March 7, 2016: 4:45 PM-6:00 PM

Convention Center, Level Two, Room 515B

1.25 CME/CE

Workshop

Moderator:

Mary Beth Fasano , MD FAAAAI

Learning Objectives:

Discuss how to structure an engaging presentation using adult learning principles
Discuss how to present your graphic data effectively for scientific presentations
Describe how to use tools other than PowerPoint to deliver effective presentations

4:45 PM

How to Structure an Engaging Presentation Using Adult Learning Principles
Asriani M. Chiu, MD FAAAAI

5:00 PM

Question & Answer

5:10 PM

Presenting Your Graphic Data Effectively for Scientific Presentations
Gerald B. Lee, MD

5:25 PM

Question & Answer

5:35 PM

Beyond PowerPoint: When Other Tools Can Tell the Story
Tao T. Le, MD MHS FAAAAI

5:50 PM

Question & Answer

4814

Pulmonary Function Testing (PFT) TICKETED
Session Details

Monday, March 7, 2016: 4:45 PM-6:00 PM

Convention Center, Level Two, Room 518

1.25 CME/CE

Workshop

Moderator:

Mark F. Sands , MD FAAAAI

Learning Objectives:

Describe PFT manifestations of obstructive and restrictive lung disease
Recognize obstructive and restrictive lung disease patterns on the flow volume loop
Recognize variable and fixed obstructive patterns including vocal cord dysfunction and describe technically acceptable PFTs; Recognize fixed vs. reversible obstruction; Differentiate parenchymal from extrinsic restrictive defects

Instructor
Donald W. Cockcroft, MD FAAAAI

4:45 PM

Small Group Discussion

Instructor
Donald P. Tashkin, MD

Instructor
Riccardo Polosa, MD PhD FAAAAI

Instructor
Mark F. Sands, MD FAAAAI

Handouts

PFT Case Handout_2016 AAAAI Workshop 4814_Final for upload.pdf (2.3 MB)

LUNG FUNCTION Interpretation Rubric_Cockcroft_workshop 4814_2016 AAAAI.pdf (180.7 kB)

Instructor
John M. Weiler, MD FAAAAI

Instructor
Eric C Kleerup, MD

4815

Update on Asthma Treatment: Evidence-Based Recommendations for 2016
Session Details

Monday, March 7, 2016: 4:45 PM-6:00 PM

Convention Center, Level One, Concourse Hall Room 152

1.25 CME/CE

Workshop - Panel Discussion

Moderator:

Steve N. Georas , MD

Learning Objectives:

Describe current controversies about the use of LABA in asthma, including FDA guidelines about step-down therapy, and describe post-marketing studies currently being conducted to examine LABA safety by comparing LABA/ICS combination inhalers with ICS alone
Discuss and examine the clinical evidence behind use of LAMA in asthma and evidence-based criteria guiding patient selection
Discuss the basis for and practical approaches to step-down therapy once asthma control has been achieved

4:45 PM

Panel Discussion

Panelist
Sally M. Seymour, MD

Handouts

Workshop 4815 Asthma Update Clinical Scenarios.pdf (224.4 kB)

Panelist
Matthew A. Rank, MD FAAAAI

Handouts

SD-AAAAI-2016.pdf (114.3 kB)

Panelist
Stanley J. Szefler, MD FAAAAI

Handouts

Szefler Handout AAAAI 030716 4815 Panel.pdf (114.6 kB)

5:30 PM

Question & Answer

4816

New Approaches to Induce Tolerance and Modify the Natural History of Allergic Diseases
Session Details

Monday, March 7, 2016: 4:45 PM-6:00 PM

Convention Center, Level One, Petree Hall C

1.25 CME/CE

Workshop

Moderator:

Paul Bryce , PhD

Learning Objectives:

Identify new studies into alternatives to SCIT and SLIT and analyze trial results
Investigate the immunological bases for allergy and determine how to influence them from very early inception onward
Develop new methods of administration, including epicutaneous immunotherapy

4:45 PM

Immunologic Routes We Can Influence to Enhance Tolerance
Mubeccel Akdis, MD PhD

Handouts

Zaleska,Akdis.pdf (777.1 kB)

5:00 PM

Question & Answer

5:10 PM

Epicutaneous Immunotherapy: Could This be the Food Allergy Treatment for the Future?
A. Wesley Burks, MD FAAAAI

5:25 PM

Question & Answer

5:35 PM

B and T Cell Epitope Peptides: Ultra-Short AIT Schedules Can be Effective
Rudolf Valenta, MD

5:50 PM

Question & Answer

Thursday, March 3, 2016

7:20 AM-5:00 PM

8:00 AM-5:00 PM

9:00 AM-12:00 PM

12:15 PM-1:15 PM

2:00 PM-5:00 PM

Friday, March 4, 2016

7:00 AM-9:30 AM

7:00 AM-1:45 PM

7:30 AM-1:45 PM

8:00 AM-9:15 AM

8:00 AM-12:30 PM

9:30 AM-10:45 AM

10:00 AM-12:30 PM

11:00 AM-12:15 PM

12:30 PM-1:45 PM

12:45 PM-1:45 PM

4:00 PM-5:15 PM

Saturday, March 5, 2016

6:45 AM-7:45 AM

7:45 AM-9:00 AM

9:15 AM-10:30 AM

10:45 AM-12:00 PM

12:30 PM-1:30 PM

2:00 PM-3:15 PM

3:30 PM-4:30 PM

4:45 PM-6:00 PM

Sunday, March 6, 2016

6:45 AM-7:45 AM

7:00 AM-8:00 AM

10:45 AM-12:00 PM

12:30 PM-1:30 PM

12:30 PM-1:45 PM

3:30 PM-4:30 PM

Monday, March 7, 2016

6:45 AM-7:45 AM

9:00 AM-4:00 PM

10:45 AM-12:00 PM

3:30 PM-4:30 PM

4:45 PM-6:00 PM